<SEC-DOCUMENT>0000947871-25-000621.txt : 20250620
<SEC-HEADER>0000947871-25-000621.hdr.sgml : 20250620
<ACCEPTANCE-DATETIME>20250620160824
ACCESSION NUMBER:		0000947871-25-000621
CONFORMED SUBMISSION TYPE:	S-3ASR
PUBLIC DOCUMENT COUNT:		17
FILED AS OF DATE:		20250620
DATE AS OF CHANGE:		20250620
EFFECTIVENESS DATE:		20250620

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			QUEST DIAGNOSTICS INC
		CENTRAL INDEX KEY:			0001022079
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MEDICAL LABORATORIES [8071]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				161387862
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-3ASR
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-288188
		FILM NUMBER:		251061400

	BUSINESS ADDRESS:	
		STREET 1:		500 PLAZA DRIVE
		CITY:			SECAUCUS
		STATE:			NJ
		ZIP:			07094
		BUSINESS PHONE:		9735202700

	MAIL ADDRESS:	
		STREET 1:		500 PLAZA DRIVE
		CITY:			SECAUCUS
		STATE:			NJ
		ZIP:			07094

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CORNING CLINICAL LABORATORIES INC
		DATE OF NAME CHANGE:	19960903
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-3ASR
<SEQUENCE>1
<FILENAME>ss4963221_s3asr.htm
<DESCRIPTION>REGISTRATION STATEMENT
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>


<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 12pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: center">As filed with the Securities and Exchange Commission
on June 20, 2025</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid">Registration
No. 333-</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: center">UNITED STATES</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: center">SECURITIES AND EXCHANGE COMMISSION</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: center">Washington, D.C. 20549</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: center">__________________</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: center">FORM S-3</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: center">REGISTRATION STATEMENT UNDER THE SECURITIES
ACT OF 1933</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: center">__________________</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: center">QUEST DIAGNOSTICS INCORPORATED</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Exact name of Registrant as specified in its
charter)</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: center">Delaware</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: center">(State or other jurisdiction of incorporation
or organization)</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: center">16-1387862</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: center">(I.R.S. Employer Identification No.)</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: center">Quest Diagnostics Incorporated</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: center">500 Plaza Drive</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: center">Secaucus, NJ 07094</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: center">(973) 520-2700</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Address, including zip code, and telephone
number, including area code,<BR>
of registrant&#8217;s principal executive offices)</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: center">__________________</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: center">Sean D. Mersten</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: center">Vice President and Corporate Secretary<BR>
Quest Diagnostics Incorporated<BR>
500 Plaza Drive</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: center">Secaucus, NJ 07094</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: center">(973) 520-2700</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Name, address, and telephone number of agent
for service)</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: center">__________________</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: center">Copies to:</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: center">Erika Kent<BR>
Lona Nallengara<BR>
Allen Overy Shearman Sterling US LLP<BR>
599 Lexington Avenue<BR>
New York, New York 10022<BR>
(212) 848-4000</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: center">__________________</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Approximate date of
commencement of proposed sale to the public</B>: From time to time after the effective date of this registration statement.</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">If the only securities
being registered on this form are being offered pursuant to dividend or interest reinvestment plans, please check the following box. <FONT STYLE="font-family: Segoe UI Symbol,sans-serif">&#9744;</FONT></P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">If any of the securities
being registered on this form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933,
other than securities offered only in connection with dividend or interest reinvestment plans, check the following box. <FONT STYLE="font-family: Segoe UI Symbol,sans-serif">&#9745;</FONT></P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 12pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">If this form is filed to
register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, check the following box and list the
Securities Act registration statement number of the earlier effective registration statement for the same offering. <FONT STYLE="font-family: Segoe UI Symbol,sans-serif">&#9744;</FONT></P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">If this form is a post-effective
amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement
number of the earlier effective registration statement for the same offering. <FONT STYLE="font-family: Segoe UI Symbol,sans-serif">&#9744;</FONT></P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">If this form is a registration
statement pursuant to General Instruction I.D. or a post-effective amendment thereto that shall become effective upon filing with the
Commission pursuant to Rule 462(e) under the Securities Act, check the following box. <FONT STYLE="font-family: Segoe UI Symbol,sans-serif">&#9745;</FONT></P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">If this form is a post-effective
amendment to a registration statement filed pursuant to General Instruction I.D. filed to register additional securities or additional
classes of securities pursuant to Rule 413(b) under the Securities Act, check the following box. <FONT STYLE="font-family: Segoe UI Symbol,sans-serif">&#9744;</FONT></P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Indicate by check mark
whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an
emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller
reporting company&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%; padding: 0.25pt; font: 10pt/12.5pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Segoe UI Symbol,sans-serif; font-size: 10pt">&#9745;</FONT> <FONT STYLE="font-size: 10pt">Large accelerated filer</FONT></TD>
    <TD STYLE="width: 5%; padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="width: 35%; padding: 0.25pt; font: 10pt/12.5pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Segoe UI Symbol,sans-serif; font-size: 10pt">&#9744;</FONT> <FONT STYLE="font-size: 10pt">Accelerated filer</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; padding: 0.25pt"><FONT STYLE="font-family: Segoe UI Symbol,sans-serif; font-size: 10pt">&#9744;</FONT> <FONT STYLE="font-size: 10pt">Non-accelerated filer </FONT></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; padding: 0.25pt"><FONT STYLE="font-family: Segoe UI Symbol,sans-serif; font-size: 10pt">&#9744;</FONT> <FONT STYLE="font-size: 10pt">Smaller reporting company</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; padding: 0.25pt"><FONT STYLE="font-family: Segoe UI Symbol,sans-serif; font-size: 10pt">&#9744;</FONT> <FONT STYLE="font-size: 10pt">Emerging growth company</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 7(a)(2)(B) of Securities Act. <FONT STYLE="font-family: Segoe UI Symbol,sans-serif">&#9744;</FONT></P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: center">____________________________________________________________</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: center"><BR>
<BR>
<BR>
</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 2; Options: NewSection -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0">PROSPECTUS</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>QUEST DIAGNOSTICS INCORPORATED</B></P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Debt Securities</B></P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">We may offer and sell,
from time to time, in one or more offerings, the debt securities we describe in this prospectus.</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">We will provide the specific
terms of these debt securities in supplements or other offering material.</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>We urge you to read
carefully this prospectus, the accompanying prospectus supplements and other offering material, which will describe the specific terms
of the securities offered, before you make your investment decision</B>.</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">We may offer and sell these
debt securities for sale directly to purchasers or through underwriters, dealers or agents to be designated at a future date. See &#8220;Plan
of Distribution&#8221; and any prospectus supplement for a description of the manner in which we will offer and sell the debt securities
covered by this prospectus.</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Investing in our debt
securities involves risks that are described in the &#8220;Risk Factors&#8221; section of our periodic reports filed with the Securities
and Exchange Commission or in the applicable prospectus supplement</B>.</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The relevant prospectus
supplement will contain information, if applicable, as to whether the debt securities offered thereby will be listed for trading on any
securities exchange or other market.</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Neither the Securities
and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy
or accuracy of this prospectus. Any representation to the contrary is a criminal offense</B>.</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: center">The date of this prospectus is June 20, 2025.</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>TABLE OF CONTENTS</B></P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>Page</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD STYLE="width: 91%; padding: 1.75pt; line-height: 12.5pt"><FONT STYLE="font-size: 10pt"><A HREF="#a_001">ABOUT THIS PROSPECTUS</A></FONT></TD>
    <TD STYLE="width: 9%; padding: 1.75pt; text-align: right; line-height: 12.5pt"><FONT STYLE="font-size: 10pt">ii</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="padding: 1.75pt; line-height: 12.5pt"><FONT STYLE="font-size: 10pt"><A HREF="#a_002">WHERE YOU CAN FIND MORE INFORMATION</A></FONT></TD>
    <TD STYLE="padding: 1.75pt; text-align: right; line-height: 12.5pt"><FONT STYLE="font-size: 10pt">ii</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD STYLE="padding: 1.75pt; line-height: 12.5pt"><FONT STYLE="font-size: 10pt"><A HREF="#a_003">CAUTIONARY STATEMENT FOR PURPOSES OF THE &#8220;SAFE HARBOR&#8221; PROVISIONS OF THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995</A></FONT></TD>
    <TD STYLE="padding: 1.75pt; text-align: right; line-height: 12.5pt"><FONT STYLE="font-size: 10pt">iii</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="padding: 1.75pt; line-height: 12.5pt"><FONT STYLE="font-size: 10pt"><A HREF="#a_004">PROSPECTUS SUMMARY</A></FONT></TD>
    <TD STYLE="padding: 1.75pt; text-align: right; line-height: 12.5pt"><FONT STYLE="font-size: 10pt">1</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD STYLE="padding: 1.75pt; line-height: 12.5pt"><FONT STYLE="font-size: 10pt"><A HREF="#a_005">RISK FACTORS</A></FONT></TD>
    <TD STYLE="padding: 1.75pt; text-align: right; line-height: 12.5pt"><FONT STYLE="font-size: 10pt">2</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="padding: 1.75pt; line-height: 12.5pt"><FONT STYLE="font-size: 10pt"><A HREF="#a_006">USE OF PROCEEDS</A></FONT></TD>
    <TD STYLE="padding: 1.75pt; text-align: right; line-height: 12.5pt"><FONT STYLE="font-size: 10pt">3</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD STYLE="padding: 1.75pt; line-height: 12.5pt"><FONT STYLE="font-size: 10pt"><A HREF="#a_007">SECURITIES WE MAY ISSUE</A></FONT></TD>
    <TD STYLE="padding: 1.75pt; text-align: right; line-height: 12.5pt"><FONT STYLE="font-size: 10pt">4</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="padding: 1.75pt; line-height: 12.5pt"><FONT STYLE="font-size: 10pt"><A HREF="#a_008">DESCRIPTION OF SENIOR DEBT SECURITIES</A></FONT></TD>
    <TD STYLE="padding: 1.75pt; text-align: right; line-height: 12.5pt"><FONT STYLE="font-size: 10pt">5</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD STYLE="padding: 1.75pt; line-height: 12.5pt"><FONT STYLE="font-size: 10pt"><A HREF="#a_009">PLAN OF DISTRIBUTION</A></FONT></TD>
    <TD STYLE="padding: 1.75pt; text-align: right; line-height: 12.5pt"><FONT STYLE="font-size: 10pt">6</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="padding: 1.75pt; line-height: 12.5pt"><FONT STYLE="font-size: 10pt"><A HREF="#a_010">VALIDITY OF THE SECURITIES</A></FONT></TD>
    <TD STYLE="padding: 1.75pt; text-align: right; line-height: 12.5pt"><FONT STYLE="font-size: 10pt">7</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD STYLE="padding: 1.75pt; line-height: 12.5pt"><FONT STYLE="font-size: 10pt"><A HREF="#a_011">EXPERTS</A></FONT></TD>
    <TD STYLE="padding: 1.75pt; text-align: right; line-height: 12.5pt"><FONT STYLE="font-size: 10pt">7</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Options: NewSection -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; width: 100%"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><A NAME="a_001" TITLE="abouthisprospectus"></A>ABOUT THIS PROSPECTUS</B></P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The information contained
in this prospectus is not complete and may be changed. We have not authorized anyone to provide you with any information or to make any
representation not contained in or incorporated by reference into this prospectus or any prospectus supplement or included in any free
writing prospectus that we may file with the Securities and Exchange Commission (the &#8220;SEC&#8221;), in connection with any offering
of the debt securities described in this prospectus. We do not take any responsibility for, and can provide no assurances as to, the reliability
of any information that others may provide you. We are not making an offer of any securities in any jurisdiction where the offer is not
permitted. You should not assume that the information in this prospectus, any prospectus supplement or any document incorporated by reference
is accurate as of any date other than the date of the document in which such information is contained or such other date referred to in
such document, regardless of the time of any sale or issuance of a security.</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">This prospectus is part
of a registration statement that we filed with the SEC using a &#8220;shelf&#8221; registration process. This prospectus provides you
with a limited description of the securities we may offer. Each time we sell or issue securities, we will provide a prospectus supplement
and, if applicable, a pricing supplement, that will contain specific information about the terms of that specific offering of securities
and the specific manner in which they may be offered. The prospectus supplement and any applicable pricing supplement may also add to,
update or change any of the information contained in this prospectus. The prospectus supplement and any applicable pricing supplement
may also contain information about any material U.S. federal income tax considerations relating to the securities described in the prospectus
supplement. You should read both this prospectus, the applicable prospectus supplement and any applicable pricing supplement, together
with the additional information, which is incorporated by reference in this prospectus, described under &#8220;Where You Can Find More
Information.&#8221; You should read the entire prospectus and the applicable prospectus supplement, including the information incorporated
by reference, before making an investment decision.</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">As used in this prospectus,
the terms &#8220;Quest Diagnostics,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us&#8221; and &#8220;our&#8221; refer to
Quest Diagnostics Incorporated and its consolidated subsidiaries, unless the context clearly indicates otherwise.</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">This prospectus contains
summaries of certain provisions contained in some of the documents described herein, but reference is made to the actual document for
complete information. All of the summaries are qualified in their entirety by the actual documents. Copies of some of the documents referred
to herein have been filed or will be filed or incorporated by reference as exhibits to the registration statement of which this prospectus
is a part, and you may obtain copies of those documents as described below under &#8220;Where You Can Find More Information.&#8221;</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The registration statement
that contains this prospectus (including the exhibits to the registration statement) contains additional information about us and the
securities offered under this prospectus. That registration statement can be read at the SEC website (www.sec.gov).</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><A NAME="a_002" TITLE="moreinformation"></A>WHERE YOU CAN FIND MORE INFORMATION</B></P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">We file annual, quarterly
and current reports, proxy statements and other information with the SEC. Our filings are available to the public on the Internet, through
a database maintained by the SEC at http://www.sec.gov.</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The SEC allows us to incorporate
by reference into this document the information we filed with the SEC. This means that we can disclose important business, financial and
other information to you by referring you to other documents separately filed with the SEC. All information incorporated by reference
is part of this document, unless and until that information is updated and superseded by the information contained in this document, any
prospectus supplement or in any document that we file with the SEC after the date hereof that is incorporated herein.</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; width: 100%"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">We incorporate by reference
the following documents filed with the SEC:</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">1.</TD><TD STYLE="text-align: justify">Our current reports on <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1022079/000102207925000008/dgx-20250130.htm">Form 8-K, filed with the SEC on January 30, 2025</A> (current report filed under Item
8.01 only) and <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1022079/000102207925000154/dgx-20250515.htm">May 22, 2025</A>;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">2.</TD><TD STYLE="text-align: justify">Our annual report on <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1022079/000102207925000044/dgx-20241231.htm">Form 10-K for the fiscal year ended December 31, 2024</A> (the &#8220;2024 Form 10-K&#8221;);</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">3.</TD><TD STYLE="text-align: justify">Portions of our proxy statement on<A HREF="https://www.sec.gov/Archives/edgar/data/1022079/000093041325001171/c111937_def14a-ixbrl.htm"> Schedule 14A, filed with the SEC on April 4, 2025</A>, that are incorporated
by reference into Part III of our Form 10-K for the fiscal year ended December 31, 2024; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">4.</TD><TD STYLE="text-align: justify">Our quarterly report on <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1022079/000102207925000120/dgx-20250331.htm">Form 10-Q for the quarter ended March 31, 2025</A>.</TD></TR></TABLE>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">We also incorporate by
reference all future filings we make with the SEC under Sections 13(a), 13(c), 14 or 15(d) of the Securities Exchange Act of 1934, as
amended (the &#8220;Exchange Act&#8221;), prior to the completion of the offering of the particular securities covered by a prospectus
supplement or term sheet.</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Our filings with the SEC,
including our annual report on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K and amendments to those reports,
are available free of charge on our website as soon as reasonably practicable after they are filed with, or furnished to, the SEC.</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">You also may request a
copy of these filings, at no cost, by writing or telephoning our Investor Relations Department at the following address:</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: center">Quest Diagnostics Incorporated<BR>
500 Plaza Drive<BR>
Secaucus, New Jersey 07094<BR>
Attention: Investor Relations<BR>
(973) 520-2900</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">These filings may also
be obtained from our internet website located at http://www.questdiagnostics.com. The contents of the website are not incorporated by
reference into this prospectus.</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><A NAME="a_003" TITLE="cautionarystatement"></A>CAUTIONARY STATEMENT FOR PURPOSES OF THE
&#8220;SAFE HARBOR&#8221; PROVISIONS OF THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995</B></P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Some statements and disclosures
in this prospectus, any accompanying prospectus supplement or other offering material and the documents incorporated herein or therein
by reference are forward-looking statements. Forward-looking statements include all statements that do not relate solely to historical
or current facts and can be identified by the use of words such as &#8220;may,&#8221; &#8220;believe,&#8221; &#8220;will,&#8221; &#8220;expect,&#8221;
&#8220;project,&#8221; &#8220;estimate,&#8221; &#8220;anticipate,&#8221; &#8220;plan,&#8221; &#8220;aim,&#8221; &#8220;endeavor&#8221;
or &#8220;continue.&#8221; These forward-looking statements are based on our current plans and expectations and are subject to a number
of risks and uncertainties that could cause our plans and expectations, including actual results, to differ materially from the forward-looking
statements.</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Private Securities
Litigation Reform Act of 1995, or the Litigation Reform Act, provides a &#8220;safe harbor&#8221; for forward-looking statements to encourage
companies to provide prospective information about their companies without fear of litigation. We would like to take advantage of the
&#8220;safe harbor&#8221; provisions of the Litigation Reform Act in connection with the forward-looking statements included or incorporated
by reference in this document. Investors are cautioned not to unduly rely on such forward-looking statements when evaluating the information
presented or incorporated by reference in this document. The following important factors could cause our actual financial results to differ
materially from those projected, forecasted or estimated by us in forward-looking statements:</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/125% Times New Roman, Times, Serif; margin: 0 0 0 0.3in; text-indent: -0.3in">(a)&nbsp;&nbsp;&nbsp;&nbsp;Heightened
competition from commercial clinical testing companies, hospitals, physicians and others.</P>

<P STYLE="font: 10pt/125% Times New Roman, Times, Serif; margin: 0 0 0 0.3in; text-indent: -0.3in">(b)&nbsp;&nbsp;&nbsp;&nbsp;Increased
pricing pressure from customers, including payers and patients, and changing relationships with customers, payers, suppliers or strategic
partners.</P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; width: 100%"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iii<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/125% Times New Roman, Times, Serif; margin: 0 0 0 0.3in; text-indent: -0.3in">(c)&nbsp;&nbsp;&nbsp;&nbsp;A decline
in, or uncertain and volatile, economic conditions, including the impact of an inflationary environment.</P>

<P STYLE="font: 10pt/125% Times New Roman, Times, Serif; margin: 0 0 0 0.3in; text-indent: -0.3in">(d)&nbsp;&nbsp;&nbsp;&nbsp;Impact of
changes in payment mix, including increased patient financial responsibility and any shift from fee-for-service to discounted, risk-sharing,
capitated or bundled fee arrangements.</P>

<P STYLE="font: 10pt/125% Times New Roman, Times, Serif; margin: 0 0 0 0.3in; text-indent: -0.3in">(e)&nbsp;&nbsp;&nbsp;&nbsp;Adverse
actions by government or other third-party payers, including healthcare reform that focuses on reducing healthcare costs but does not
recognize the value and importance to healthcare of clinical testing or innovative solutions, unilateral reduction of fee schedules payable
to us, unilateral recoupment of amounts allegedly owed and competitive bidding.</P>

<P STYLE="font: 10pt/125% Times New Roman, Times, Serif; margin: 0 0 0 0.3in; text-indent: -0.3in">(f)&nbsp;&nbsp;&nbsp;&nbsp;The impact
upon our testing volume and collected revenue or general or administrative expenses resulting from compliance with policies and requirements
imposed by Medicare, Medicaid and other third-party payers. These include:</P>

<P STYLE="font: 10pt/125% Times New Roman, Times, Serif; margin: 0 0 0 0.6in; text-indent: -0.3in">(1)&nbsp;&nbsp;&nbsp;&nbsp;the requirements
of government and other payers to provide diagnosis codes and other information for many tests;</P>

<P STYLE="font: 10pt/125% Times New Roman, Times, Serif; margin: 0 0 0 0.6in; text-indent: -0.3in">(2)&nbsp;&nbsp;&nbsp;&nbsp;inability
to obtain from patients a valid advance consent form for tests that cannot be billed without prior receipt of the form;</P>

<P STYLE="font: 10pt/125% Times New Roman, Times, Serif; margin: 0 0 0 0.6in; text-indent: -0.3in">(3)&nbsp;&nbsp;&nbsp;&nbsp;the impact
of additional or expanded limited coverage policies and limits on the allowable number of test units or ordering frequency of same; and</P>

<P STYLE="font: 10pt/125% Times New Roman, Times, Serif; margin: 0 0 0 0.6in; text-indent: -0.3in">(4)&nbsp;&nbsp;&nbsp;&nbsp;the impact
of increased prior authorization programs.</P>

<P STYLE="font: 10pt/125% Times New Roman, Times, Serif; margin: 0 0 0 0.3in; text-indent: -0.3in">(g)&nbsp;&nbsp;&nbsp;&nbsp;Adverse
results from pending or future government investigations, lawsuits or private actions. These include, in particular, monetary damages,
loss or suspension of licenses, and/or suspension or exclusion from the Medicare and Medicaid programs and/or criminal penalties.</P>

<P STYLE="font: 10pt/125% Times New Roman, Times, Serif; margin: 0 0 0 0.3in; text-indent: -0.3in">(h)&nbsp;&nbsp;&nbsp;&nbsp;Failure
to efficiently integrate acquired businesses and to manage the costs related to any such integration, or to retain key technical, professional
or management personnel.</P>

<P STYLE="font: 10pt/125% Times New Roman, Times, Serif; margin: 0 0 0 0.3in; text-indent: -0.3in">(i)&nbsp;&nbsp;&nbsp;&nbsp;Denial,
suspension or revocation of Clinical Laboratory Improvement Act (&#8220;CLIA&#8221;) certification or other licenses for any of our clinical
laboratories under the CLIA standards, revocation or suspension of the right to bill the Medicare and Medicaid programs or other adverse
regulatory actions by federal, state and local agencies.</P>

<P STYLE="font: 10pt/125% Times New Roman, Times, Serif; margin: 0 0 0 0.3in; text-indent: -0.3in">(j)&nbsp;&nbsp;&nbsp;&nbsp;Changes
in and complexity of federal, state or local laws, policies or regulations, including changes that result in new or increased federal
or state regulation of commercial clinical laboratories, tests developed by commercial clinical laboratories or other products or services
that we offer or activities in which we are engaged, including regulation by the U.S. Food and Drug Administration, and including related
to trade.</P>

<P STYLE="font: 10pt/125% Times New Roman, Times, Serif; margin: 0 0 0 0.3in; text-indent: -0.3in">(k)&nbsp;&nbsp;&nbsp;&nbsp;Inability
to achieve expected benefits from our acquisitions of other businesses.</P>

<P STYLE="font: 10pt/125% Times New Roman, Times, Serif; margin: 0 0 0 0.3in; text-indent: -0.3in">(l)&nbsp;&nbsp;&nbsp;&nbsp; Inability
to achieve additional benefits from our business performance tools and efficiency initiatives.</P>

<P STYLE="font: 10pt/125% Times New Roman, Times, Serif; margin: 0 0 0 0.3in; text-indent: -0.3in">(m)&nbsp;&nbsp;&nbsp;Adverse publicity
and news coverage about the diagnostic information services industry or us.</P>

<P STYLE="font: 10pt/125% Times New Roman, Times, Serif; margin: 0 0 0 0.3in; text-indent: -0.3in">(n)&nbsp;&nbsp;&nbsp;&nbsp;Failure
of the Company to maintain, defend and secure its financial, accounting, technology, customer data and other operational systems from
cyberattacks, IT system outages, telecommunications failures, malicious human acts and failure of the systems of third parties upon which
the Company relies.</P>

<P STYLE="font: 10pt/125% Times New Roman, Times, Serif; margin: 0 0 0 0.3in; text-indent: -0.3in">(o)&nbsp;&nbsp;&nbsp;&nbsp;Development
of technologies that substantially alter the practice of clinical testing, including technology changes that lead to the development of
more convenient, accessible and cost-effective testing, or new testing services that can be performed outside of a commercial clinical
laboratory, such as point-of-care testing that can be administered by physicians in their offices, complex testing that can be performed
by hospitals in their own laboratories or home testing that can be carried out without requiring the services of clinical laboratories.</P>

<P STYLE="font: 10pt/125% Times New Roman, Times, Serif; margin: 0 0 0 0.3in; text-indent: -0.3in">(p)&nbsp;&nbsp;&nbsp;&nbsp;Challenges
with properly managing the development and use of artificial intelligence.</P>

<P STYLE="font: 10pt/125% Times New Roman, Times, Serif; margin: 0 0 0 0.3in; text-indent: -0.3in">(q)&nbsp;&nbsp;&nbsp;&nbsp;Negative
developments regarding intellectual property and other property rights that could prevent, limit or interfere with our ability to develop,
perform or sell our tests or operate our business. These include:</P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; width: 100%"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iv<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/125% Times New Roman, Times, Serif; margin: 0 0 0 0.6in; text-indent: -0.3in">(1)&nbsp;&nbsp;&nbsp;&nbsp;issuance
of patents or other property rights to our competitors or others; and</P>

<P STYLE="font: 10pt/125% Times New Roman, Times, Serif; margin: 0 0 0 0.6in; text-indent: -0.3in">(2)&nbsp;&nbsp;&nbsp;&nbsp;inability
to obtain or maintain adequate patent or other proprietary rights for our products and services or to successfully enforce our proprietary
rights.</P>

<P STYLE="font: 10pt/125% Times New Roman, Times, Serif; margin: 0 0 0 0.3in; text-indent: -0.3in">(r)&nbsp;&nbsp;&nbsp;&nbsp;Development
of tests by our competitors or others which we may not be able to license, or usage (or theft) of our technology or similar technologies
or our trade secrets or other intellectual property by competitors, any of which could negatively affect our competitive position.</P>

<P STYLE="font: 10pt/125% Times New Roman, Times, Serif; margin: 0 0 0 0.3in; text-indent: -0.3in">(s)&nbsp;&nbsp;&nbsp;&nbsp; Regulatory
delay or inability to commercialize newly developed or licensed tests or technologies or to obtain appropriate reimbursements for such
tests.</P>

<P STYLE="font: 10pt/125% Times New Roman, Times, Serif; margin: 0 0 0 0.3in; text-indent: -0.3in">(t)&nbsp;&nbsp;&nbsp;&nbsp;The complexity
of billing and revenue recognition for clinical laboratory testing.</P>

<P STYLE="font: 10pt/125% Times New Roman, Times, Serif; margin: 0 0 0 0.3in; text-indent: -0.3in">(u)&nbsp;&nbsp;&nbsp; &nbsp;Increases
in interest rates and negative changes in our credit ratings from Standard &amp; Poor&#8217;s, Moody&#8217;s Investor Services or Fitch
Ratings causing an unfavorable impact on our cost of or access to capital.</P>

<P STYLE="font: 10pt/125% Times New Roman, Times, Serif; margin: 0 0 0 0.3in; text-indent: -0.3in">(v)&nbsp;&nbsp;&nbsp;&nbsp;Inability
to hire or retain qualified employees, including key senior management personnel, and maintain good relations with our employees.</P>

<P STYLE="font: 10pt/125% Times New Roman, Times, Serif; margin: 0 0 0 0.3in; text-indent: -0.3in">(w)&nbsp;&nbsp;&nbsp;Terrorist and
other criminal activities, hurricanes, earthquakes or other natural disasters, geopolitical matters, public health emergencies and pandemics,
which could affect our customers or suppliers, transportation or systems, or our facilities, and for which insurance may not adequately
reimburse us.</P>

<P STYLE="font: 10pt/125% Times New Roman, Times, Serif; margin: 0 0 0 0.3in; text-indent: -0.3in">(x)&nbsp;&nbsp;&nbsp;Difficulties and
uncertainties in the discovery, development, regulatory environment and/or marketing of new services or solutions or new uses of existing
tests.</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt/125% Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.3in">(y)</TD><TD><FONT STYLE="background-color: white">Failure to adapt to changes in the healthcare system (including the medical laboratory testing
market) and healthcare delivery, including those stemming from the Protecting Access to Medicare Act, trends in utilization of the healthcare
system and increased patient financial responsibility for services.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/125% Times New Roman, Times, Serif; margin: 0 0 0 0.3in; text-indent: -0.3in">(z) &nbsp;&nbsp;&nbsp;&nbsp;Results
and consequences of governmental inquiries.</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt/125% Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.3in">(aa)</TD><TD>Difficulty in implementing, or lack of success with, our strategic plan.</TD></TR></TABLE>

<P STYLE="font: 10pt/125% Times New Roman, Times, Serif; margin: 0 0 0 0.3in; text-indent: -0.3in">(bb) The impact of healthcare data
analysis on our industry and the ability of our Company to adapt to that impact.</P>

<P STYLE="font: 10pt/125% Times New Roman, Times, Serif; margin: 0 0 0 0.3in; text-indent: -0.3in">(cc) Failure to adequately operationalize
appropriate controls around use of our data, including risk of non- compliance with privacy law requirements.</P>

<P STYLE="font: 10pt/125% Times New Roman, Times, Serif; margin: 0 0 0 0.3in; text-indent: -0.3in">(dd) Any future public health emergency
or pandemic.</P>

<P STYLE="font: 10pt/125% Times New Roman, Times, Serif; margin: 0 0 0 0.3in; text-indent: -0.3in">(ee) Other risks outlined in our periodic
filings with the SEC.</P>

<P STYLE="font: 10pt/125% Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/125% Times New Roman, Times, Serif; margin: 0">Our forward-looking statements are expressly qualified in their entirety
by this cautionary statement. We undertake no obligation to update our forward-looking statements to reflect new information or events
or circumstances arising after the date such forward-looking statements were made.</P>

<P STYLE="font: 10pt/125% Times New Roman, Times, Serif; margin: 0 0 0 0.3in; text-indent: -0.3in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.3in; text-indent: -0.3in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.3in; text-indent: -0.3in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.3in; text-indent: -0.3in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.3in; text-indent: -0.3in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.3in; text-indent: -0.3in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.3in; text-indent: -0.3in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.3in; text-indent: -0.3in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.3in; text-indent: -0.3in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.3in; text-indent: -0.3in">&nbsp;</P>


<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; width: 100%"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->v<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-align: center"><A NAME="a_004" TITLE="prospectussummary"></A><B>PROSPECTUS SUMMARY</B></P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><I>This summary highlights some of the information
incorporated by reference into this prospectus. Because this is only a summary, it does not contain all of the information that may be
important to you. You should carefully read this prospectus, the applicable prospectus supplement, and any other offering material including
the documents incorporated by reference, which are described under &#8220;Where You Can Find More Information.&#8221; You should also
carefully consider, among other things, the matters discussed in the section entitled &#8220;Risk Factors.&#8221;<BR>
<BR>
</I></P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0"><B>The Company<BR>
<BR>
</B></P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Quest Diagnostics works across the healthcare
ecosystem to create a healthier world, one life at a time. Our diagnostic information services business provides diagnostic insights from
the results of our laboratory testing to empower people, physicians, and organizations to take action to improve health outcomes. Derived
from one of the world&#8217;s largest databases of de-identifiable clinical lab results, our diagnostic insights reveal new avenues to
identify and treat disease, inspire healthy behaviors and improve healthcare management. In the right hands and with the right context,
our diagnostic insights can inspire actions that transform lives and create a healthier world. We provide services to a broad range of
customers within our primary customer channels - physicians (including those associated with accountable care organizations and Federally
Qualified Health Centers), hospitals, and patients and consumers. Our other customers include health plans, employers, emerging retail
healthcare providers, government agencies, pharmaceutical companies and other commercial clinical laboratories. We offer broad access
to clinical testing through a nationwide network of laboratories, patient service centers, phlebotomists in physician offices, and our
connectivity resources, including call centers and mobile phlebotomists, nurses and other health and wellness professionals. Our large
in-house staff of medical and scientific experts, including medical directors, scientific directors, genetic counselors and board-certified
geneticists, provide medical and scientific consultation to healthcare providers and patients regarding our tests and test results, and
help them best utilize our services to improve outcomes and enhance satisfaction. During 2024, we processed approximately 217 million
test requisitions through our extensive laboratory network.</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Our Diagnostic Solutions group, which represents
the balance of our consolidated net revenues, includes our risk assessment services business, which offers solutions for insurers, and
our healthcare information technology businesses, which offer solutions for healthcare providers and payers.</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The patients we serve annually comprise approximately
one-third of the adult population of the United States, and over a three-year period, we serve approximately one-half of the adult population
of the United States. We estimate that annually we serve approximately half of the physicians and half of the hospitals in the United
States.</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Quest Diagnostics was incorporated in Delaware
in 1990; its predecessor companies date back to 1967. We conduct business through our headquarters in Secaucus, New Jersey, and our laboratories,
patient service centers, offices and other facilities around the United States and in selected locations outside the United States.&nbsp;During
2024, we generated net revenues of $9.9 billion.</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Our principal executive offices are located
at 500 Plaza Drive, Secaucus, New Jersey 07094, telephone number: (973) 520-2700.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 9; Options: NewSection -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; width: 100%"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><A NAME="a_005" TITLE="riskfactors"></A>RISK FACTORS</B></P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Our business is subject to significant risks.
You should carefully consider the risks and uncertainties set forth in Part I, Item 1A. under the heading &#8220;Risk Factors&#8221; included
in our 2024 Form 10-K and in &#8220;Item 1A. Risk Factors&#8221; in any quarterly report on Form 10-Q, which are incorporated by reference
in this prospectus. Additional risk factors that you should carefully consider will also be included in a prospectus supplement relating
to an offering of our securities as well as the other documents filed with the SEC that are incorporated by reference herein or therein.</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The risks and uncertainties described in any
accompanying prospectus supplement as well as the documents incorporated by reference herein or therein are not the only ones facing us.
Additional risks and uncertainties that we do not presently know about or that we currently believe are not material may also adversely
affect our business. If any of the risks and uncertainties described in this prospectus, any accompanying prospectus supplement or the
documents incorporated by reference herein or therein actually occur, our business, financial condition, results of operations and prospects
could be adversely affected in a material way. The occurrence of any of these risks may cause you to lose all or part of your investment
in the offered securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; width: 100%"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-align: center"><B><A NAME="a_006" TITLE="useofproceeds"></A>USE OF PROCEEDS</B></P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Except as may be described
otherwise in a prospectus supplement or other offering material, we will add the net proceeds from the sale of the securities under this
prospectus to our general funds and will use them for general corporate purposes, which may include, among other things, funding acquisitions,
capital expenditures, or reducing or refinancing indebtedness.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; width: 100%"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-align: center"><B><A NAME="a_007" TITLE="securitieswemayissue"></A>SECURITIES WE MAY ISSUE</B></P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0"><B>Overview</B></P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">This prospectus is part
of a registration statement that we filed with the SEC utilizing a &#8220;shelf&#8221; registration process. Under this shelf process,
we may sell our debt securities in one or more offerings.</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The terms of the debt securities
will be determined at the time of offering.</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0"><B>Prospectus Supplement or Pricing Supplement</B></P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">This prospectus provides
you with a general description of the debt securities we may offer. Each time we sell debt securities, we will provide a prospectus supplement
or pricing supplement that will contain specific information about the terms of that offering. The prospectus supplement or pricing supplement
may also add to or change information contained in this prospectus. If so, the prospectus supplement or pricing supplement should be read
as superseding this prospectus. You should read both this prospectus and any prospectus supplement or pricing supplement together with
additional information described under the heading &#8220;Where You Can Find More Information.&#8221;</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The prospectus supplement
or pricing supplement to be provided with this prospectus will describe the terms of any debt securities that we offer and any initial
offering price to the public in that offering, the purchase price and net proceeds that we will receive and the other specific terms related
to our offering of the debt securities. For more details on the terms of the debt securities, you should read the exhibits filed with
or incorporated by reference in our registration statement, of which this prospectus is a part.</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; width: 100%"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-align: center"><A NAME="a_008" TITLE="descriptionofseniordebt"></A><B>DESCRIPTION OF SENIOR DEBT SECURITIES<BR>
<BR>
</B></P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">We may issue senior debt
securities from time to time in one or more distinct series.</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">As required by U.S. federal
law for all bonds and notes of companies that are publicly offered, the senior debt securities will be governed by a document called an
&#8220;indenture.&#8221; An indenture is a contract between us and a financial institution, in this case, The Bank of New York Mellon
formerly known as The Bank of New York, acting as trustee on your behalf, or other trustee we may select. The indenture will be subject
to and governed by the Trust Indenture Act of 1939.</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">We have filed the indenture
as an exhibit to our Securities Act of 1933, as amended (&#8220;Securities Act&#8221;), filings and Exchange Act reports that we have
filed with the SEC. See &#8220;Where You Can Find More Information&#8221; for information on how to obtain a copy of the indenture.</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The senior debt securities will be issued under an
indenture dated as of June 27, 2001, as supplemented by the first supplemental indenture, dated as of June 27, 2001, each among Quest
Diagnostics, as issuer, the Initial Subsidiary Guarantors (as defined therein), as guarantors, and The Bank of New York, as trustee, as
further supplemented by the second supplemental indenture, dated as of November 26, 2001, among Quest Diagnostics, the Subsidiary Guarantors
(as defined therein) and The Bank of New York, as further supplemented by the third supplemental indenture, dated as of April 4, 2002,
among Quest Diagnostics, the Additional Subsidiary Guarantors (as defined therein) and The Bank of New York, as further supplemented by
the fourth supplemental indenture, dated as of March 19, 2003, among Quest Diagnostics, the Additional Subsidiary Guarantor (as defined
therein) and The Bank of New York, as further supplemented by the fifth supplemental indenture, dated as of April 16, 2004, among Quest
Diagnostics, the Additional Subsidiary Guarantor (as defined therein) and The Bank of New York, as further supplemented by the sixth supplemental
indenture, dated as of October 31, 2005, among Quest Diagnostics, the Subsidiary Guarantors (as defined therein) and The Bank of New York,
as further supplemented by the seventh supplemental indenture, dated as of November 21, 2005, among Quest Diagnostics, the Additional
Subsidiary Guarantors (as defined therein) and The Bank of New York, as further supplemented by the eighth supplemental indenture, dated
as of July 31, 2006, among Quest Diagnostics, the Additional Subsidiary Guarantors (as defined therein) and The Bank of New York, as further
supplemented by the ninth supplemental indenture, dated as of September 30, 2006, among Quest Diagnostics, the Additional Subsidiary Guarantors
(as defined therein) and The Bank of New York, as further supplemented by the tenth supplemental indenture, dated as of June 22, 2007,
among Quest Diagnostics, the Subsidiary Guarantors (as defined therein) and The Bank of New York, as further supplemented by the eleventh
supplemental indenture, dated as of June 22, 2007, among Quest Diagnostics, the Additional Subsidiary Guarantors (as defined therein)
and The Bank of New York, as further supplemented by the twelfth supplemental indenture, dated as of June 25, 2007, among Quest Diagnostics,
the Additional Subsidiary Guarantors (as defined therein) and The Bank of New York, as further supplemented by the thirteenth supplemental
indenture, dated as of November 17, 2009, among Quest Diagnostics, the Subsidiary Guarantors (as defined therein) and The Bank of New
York Mellon, as further supplemented by the fourteenth supplemental indenture, dated as of March 24, 2011, among Quest Diagnostics, the
Subsidiary Guarantors (as defined therein) and The Bank of New York Mellon, as further supplemented by the fifteenth supplemental indenture,
dated as of November 30, 2011, among Quest Diagnostics, the Additional Subsidiary Guarantors (as defined therein) and The Bank of New
York Mellon, as further supplemented by the sixteenth supplemental indenture, dated as of March 17, 2014, between Quest Diagnostics and
The Bank of New York Mellon, as further supplemented by the seventeenth supplemental indenture, dated as of March 10, 2015, between Quest
Diagnostics and The Bank of New York Mellon, as further supplemented by the eighteenth supplemental indenture, dated as of May 26, 2016,
between Quest Diagnostics and The Bank of New York Mellon, as further supplemented by the nineteenth supplemental indenture, dated as
of March 12, 2019, between Quest Diagnostics and The Bank of New York Mellon, as further supplemented by the twentieth supplemental indenture,
dated as of December 16, 2019, between Quest Diagnostics and The Bank of New York Mellon, as further supplemented by the twenty-first
supplemental indenture, dated as of May 13, 2020, between Quest Diagnostics and The Bank of New York Mellon, as further supplemented by
the twenty-second supplemental indenture, dated as of November 1, 2023, between Quest Diagnostics and The Bank of New York Mellon, and
as further supplemented by the twenty-third supplemental indenture, dated as of August 19, 2024, between Quest Diagnostics and The Bank
of New York Mellon (collectively, as so supplemented, the &#8220;Indenture&#8221;). The Indenture for the senior debt securities may also
be modified by future supplemental indentures. The terms of the senior debt securities include those stated in the Indenture and those
made part of the Indenture by reference to the Trust Indenture Act of 1939. A copy of the Indenture is available for inspection at the
office of the trustee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; width: 100%"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-align: center"><A NAME="a_009" TITLE="planofdistribution"></A><B>PLAN OF DISTRIBUTION</B></P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">We may sell the debt securities
to or through agents, dealers or underwriters or directly to one or more purchasers.</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0"><B>By Agents</B></P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">We may use agents to sell
the debt securities. Unless otherwise stated in a prospectus supplement or other offering material, the agents will agree to use their
reasonable best efforts to solicit purchases for the period of their appointment.</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0"><B>By Underwriters or Dealers</B></P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">We may sell the debt securities
to underwriters. The underwriters may resell the debt securities in one or more transactions, including negotiated transactions, at a
fixed public offering price or at varying prices determined at the time of sale. The obligations of the underwriters to purchase the debt
securities will be subject to certain conditions. Each underwriter will be obligated to purchase all the debt securities allocated to
it under the underwriting agreement. The underwriters may change any initial public offering price and any discounts or concessions they
give to dealers.</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">A prospectus supplement
and/or any additional offering material will state the name of any underwriter and the amount of compensation, underwriting discounts,
commissions, or concessions paid or allowed.</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0"><B>Direct Sales</B></P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">We may sell debt securities
directly to investors. In this case, no underwriters, dealers or agents would be involved.</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">As one of the means of
direct issuance of debt securities, we may utilize the services of any available electronic auction system to conduct an electronic &#8220;Dutch
auction&#8221; of the offered securities among potential purchasers who are eligible to participate in the auction of those offered debt
securities, if so described in the prospectus supplement or pricing supplement.</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0"><B>General Information</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">We may have agreements
with the underwriters, dealers and agents to indemnify them against certain civil liabilities, including liabilities under the Securities
Act, or to contribute to payments they may be required to make.</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Underwriters, dealers and
agents may engage in transactions with, or perform services for, us or our subsidiaries in the ordinary course of their business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; width: 100%"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-align: center"><B><A NAME="a_010" TITLE="validityofthesecurities"></A>VALIDITY OF THE SECURITIES<BR>
<BR>
</B></P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The validity of any securities
issued hereunder will be passed upon for us by Allen Overy Shearman Sterling US LLP, New York, New York.</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: center"><A NAME="a_011" TITLE="experts"></A><B>EXPERTS<BR>
<BR>
</B></P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The financial statements
and management&#8217;s assessment of the effectiveness of internal control over financial reporting (which is included in the Report of
Management on Internal Control Over Financial Reporting) incorporated in this Prospectus by reference to the Annual Report on Form 10-K
for the year ended December 31, 2024 have been so incorporated in reliance on the report of PricewaterhouseCoopers LLP, an independent
registered public accounting firm, given on the authority of said firm as experts in auditing and accounting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; width: 100%"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-align: center"><B>PART II<BR>
<BR>
</B></P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>INFORMATION NOT REQUIRED IN PROSPECTUS</B></P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0"><B>Item 14. Other Expenses of Issuance and Distribution</B>.</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The following table sets
forth all fees and expenses payable by the registrant in connection with the issuance and distribution of the securities being registered
hereby (other than underwriting discounts and commissions).</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="width: 89%; line-height: 12.5pt"><FONT STYLE="font-size: 10pt">SEC registration fee </FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 8%; text-align: right; line-height: 12.5pt"><FONT STYLE="font-size: 10pt">*</FONT></TD>
    <TD STYLE="white-space: nowrap; width: 1%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="line-height: 12.5pt"><FONT STYLE="font-size: 10pt">Legal fees and expenses </FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="line-height: 12.5pt"><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right; line-height: 12.5pt"><FONT STYLE="font-size: 10pt">+</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="line-height: 12.5pt"><FONT STYLE="font-size: 10pt">Trustee&#8217;s fees and expenses </FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="line-height: 12.5pt"><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right; line-height: 12.5pt"><FONT STYLE="font-size: 10pt">+</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="line-height: 12.5pt"><FONT STYLE="font-size: 10pt">Accounting fees and expenses </FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="line-height: 12.5pt"><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right; line-height: 12.5pt"><FONT STYLE="font-size: 10pt">+</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="line-height: 12.5pt"><FONT STYLE="font-size: 10pt">Printing expenses </FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="line-height: 12.5pt"><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right; line-height: 12.5pt"><FONT STYLE="font-size: 10pt">+</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="padding-bottom: 1.5pt; line-height: 12.5pt"><FONT STYLE="font-size: 10pt">Miscellaneous </FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; padding-bottom: 0.75pt; line-height: 12.5pt"><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; padding-bottom: 0.75pt; text-align: right; line-height: 12.5pt"><FONT STYLE="font-size: 10pt">+</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: black 1.5pt solid; padding-bottom: 0.75pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="padding-bottom: 3pt; line-height: 12.5pt"><FONT STYLE="font-size: 10pt"><B>Total </B></FONT></TD>
    <TD STYLE="padding-bottom: 3pt">&nbsp;</TD>
    <TD STYLE="border-bottom: black 2.25pt double; padding-bottom: 1.5pt; line-height: 12.5pt"><FONT STYLE="font-size: 10pt"><B>$</B></FONT></TD>
    <TD STYLE="border-bottom: black 2.25pt double; padding-bottom: 1.5pt; text-align: right; line-height: 12.5pt"><FONT STYLE="font-size: 10pt">+</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: black 2.25pt double; padding-bottom: 4.5pt">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px"><FONT STYLE="font-size: 10pt">*</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Deferred in accordance with Rules 456(b) and 457(r) of the Securities Act of 1933.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">+</FONT></TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Because an indeterminate amount of securities are covered by this registration
    statement, the expenses in connection with the issuance and distribution of securities are not currently determinable.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0"><B>Item 15. Indemnification of Directors and Officers</B>.</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0"><B><I>Limitation on Liability of Directors and Certain Officers</I></B></P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Pursuant to authority conferred by Section 102
of the Delaware General Corporation Law (the &#8220;DGCL&#8221;), Section 11 of our restated certificate of incorporation (the &#8220;Certificate&#8221;)
eliminates the personal liability of directors, including, without limitation, directors serving on committees of our board of directors,
and certain officers to us or our stockholders for monetary damages for breach of fiduciary duty. Directors and officers remain liable
for (1) any breach of the duty of loyalty to us or our stockholders, (2) any act or omission not in good faith or which involves intentional
misconduct or a knowing violation of law, (3) with respect to directors, any violation of Section 174 of the DGCL, which proscribes the
payment of dividends and stock purchases or redemptions under certain circumstances, (4) any transaction from which directors derive an
improper personal benefit, and (5) with respect to officers, any action by or in the right of the Company.</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0"><B><I>Indemnification and Insurance<BR>
<BR>
</I></B></P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">In accordance with Section 145 of the DGCL,
which provides for the indemnification of directors, officers and employees under certain circumstances, Section 7.01 of our amended and
restated by-laws (the &#8220;By-Laws&#8221;) and Section 11 of our Certificate each grant our directors and officers a right to indemnification,
to the fullest extent authorized by the DGCL, as the same exists or may hereafter be amended (but in the case of any such amendment, only
to the extent that such amendment permits the Company to provide broader indemnification rights than said law permitted the Company to
provide prior to such amendment) for all expenses, liabilities and losses reasonably incurred by each director or officer who was or is
made a party or is threatened to be made a party to or is involved in any action, suit or proceeding, whether civil, criminal, administrative
or investigative proceedings to which they are a party (1) by reason of the fact that they are or were our directors or officers or (2)
by reason of the fact that, while they are or were our directors or officers, they are or were serving at our request as directors or
officers of another corporation, partnership, joint venture, trust or enterprise including service with respect to employee benefit plans,
and such indemnification shall continue as to former directors and officers and shall inure to the benefit of such directors&#8217; and
officers&#8217; heirs, executors and administrators; provided, however, that, the Company shall indemnify any such person seeking indemnification
in connection with a proceeding (or part thereof) initiated by the person seeking indemnification only if such proceeding (or part thereof)
was authorized by the Board of Directors of the Corporation.</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 16; Options: NewSection -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; width: 100%"><TR><TD STYLE="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Each of the By-Laws and the Certificate further
provides for the mandatory advancement of expenses incurred by officers and directors in defending such proceedings in advance of their
final disposition upon delivery to us by the indemnitee of an undertaking to repay all amounts so advanced if it is ultimately determined
that such indemnitee is not entitled to be indemnified. We may not indemnify or make advance payments to any person in connection with
proceedings initiated against us by such person without the authorization of our board of directors. In addition, Section 11 of the Certificate
provides that directors and officers therein described shall be indemnified to the fullest extent permitted by Section 145 of the DGCL,
or any successor provisions or amendments thereunder.</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in">In the event that any such successor
provisions or amendments provide indemnification rights broader than permitted prior thereto, Section 11 of the Certificate allows such
broader indemnification rights to apply retroactively with respect to any predating alleged action or inaction and also allows the indemnification
to continue after an indemnitee has ceased to be our director or officer and to inure to the benefit of the indemnitee&#8217;s heirs,
executors and administrators.<BR>
<BR>
</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Each of the By-Laws and the Certificate further
provides that the right to indemnification is not exclusive of any other right that any indemnitee may have or thereafter acquire under
any statute, the Certificate, any agreement or vote of stockholders or disinterested directors or otherwise, and allows us to indemnify
and advance expenses to any person whom the corporation has the power to indemnify under the DGCL or otherwise.</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Our By-Laws further provide that should any
repeal or modification of any of the provisions of Section 7.01 occur, such changes would not adversely affect any right or protection
of any director, officer or other person in respect of any proceeding arising out of, or related to, any act or omission occurring prior
to the time of such repeal or modification.</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The form of underwriting agreement will provide
for the indemnification of the registrant, its controlling persons, its directors and certain of its officers by the underwriters against
certain liabilities, including liabilities under the Securities Act.</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Insofar as indemnification for liabilities arising
under the Securities Act may be permitted for directors and officers and controlling persons pursuant to the foregoing provisions, we
have been advised that in the opinion of the SEC, such indemnification is against public policy as expressed in the Securities Act and
is, therefore, unenforceable.</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Each of the By-Laws and the Certificate authorizes
us to purchase insurance for our directors and officers and persons who serve at our request as directors, officers, employees or agents
of another corporation, partnership, joint venture, trust or enterprise against any expense, liability or loss incurred in such capacity,
whether or not we would have the power to indemnify such persons against such expense or liability under the DGCL. We intend to maintain
insurance coverage of our officers and directors as well as insurance coverage to reimburse us for potential costs of our corporate indemnification
of directors and officers.</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; width: 100%"><TR><TD STYLE="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0"><B>Item 16. Exhibits and Financial Statements Schedules</B>.</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 13%; border-bottom: black 1.5pt solid; padding: 1.75pt 1.75pt 2.25pt; line-height: 12.5pt"><FONT STYLE="font-size: 10pt"><B>Exhibit Number</B></FONT></TD>
    <TD STYLE="width: 2%; padding: 1.75pt">&nbsp;</TD>
    <TD STYLE="width: 85%; border-bottom: black 1.5pt solid; padding: 1.75pt 1.75pt 2.25pt; line-height: 12.5pt"><FONT STYLE="font-size: 10pt"><B>Description of Exhibit</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 1.75pt; line-height: 12.5pt"><FONT STYLE="font-size: 10pt; color: Blue"><U>*1.1</U></FONT></TD>
    <TD STYLE="padding: 1.75pt"><FONT STYLE="color: #000000">&nbsp;</FONT></TD>
    <TD STYLE="padding: 1.75pt; text-align: justify; line-height: 12.5pt"><FONT STYLE="font-size: 10pt; color: Blue"><U>Form of Underwriting
    Agreement for Debt Securities.</U></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 1.75pt 1.75pt 1.75pt 4.5pt; line-height: 12.5pt"><FONT STYLE="font-size: 10pt; color: #000000"><A HREF="https://www.sec.gov/Archives/edgar/data/1022079/000094787101500290/ex4-3_062801.txt">4.1</A></FONT></TD>
    <TD STYLE="padding: 1.75pt"><FONT STYLE="color: #000000">&nbsp;</FONT></TD>
    <TD STYLE="padding: 1.75pt; text-align: justify; line-height: 12.5pt"><FONT STYLE="font-size: 10pt; color: #000000"><A HREF="https://www.sec.gov/Archives/edgar/data/1022079/000094787101500290/ex4-3_062801.txt">Indenture, dated as of June 27, 2001, among the Company, the Subsidiary Guarantors, and The Bank of New York Mellon (formerly known as The Bank of New York) (filed as an Exhibit to the Company&rsquo;s current report on Form 8-K (Date of Report: June 27, 2001) and incorporated herein by reference)</A></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 1.75pt 1.75pt 1.75pt 4.5pt; line-height: 12.5pt"><FONT STYLE="font-size: 10pt; color: #000000"><A HREF="https://www.sec.gov/Archives/edgar/data/1022079/000094787101500290/ex4-4_062801.txt">4.2</A></FONT></TD>
    <TD STYLE="padding: 1.75pt"><FONT STYLE="color: #000000">&nbsp;</FONT></TD>
    <TD STYLE="padding: 1.75pt; text-align: justify; line-height: 12.5pt"><FONT STYLE="font-size: 10pt; color: #000000"><A HREF="https://www.sec.gov/Archives/edgar/data/1022079/000094787101500290/ex4-4_062801.txt">First Supplemental Indenture, dated as of June 27, 2001, among the Company, the Initial Subsidiary Guarantors, and The Bank of New York (filed as an Exhibit to the Company&#8217;s current report on Form 8-K (Date of Report: June 27, 2001) and incorporated herein by reference)</A></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 1.75pt 1.75pt 1.75pt 4.5pt; line-height: 12.5pt"><FONT STYLE="font-size: 10pt; color: #000000"><A HREF="https://www.sec.gov/Archives/edgar/data/1022079/000094787101501115/ex4-1_112601.txt">4.3</A></FONT></TD>
    <TD STYLE="padding: 1.75pt"><FONT STYLE="color: #000000">&nbsp;</FONT></TD>
    <TD STYLE="padding: 1.75pt; text-align: justify; line-height: 12.5pt"><FONT STYLE="font-size: 10pt; color: #000000"><A HREF="https://www.sec.gov/Archives/edgar/data/1022079/000094787101501115/ex4-1_112601.txt">Second Supplemental Indenture, dated as of November 26, 2001, among the Company, the Subsidiary Guarantors, and The Bank of New York (filed as an Exhibit to the Company&#8217;s current report on Form 8-K (Date of Report: November 26, 2001) and incorporated herein by reference)</A></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 1.75pt 1.75pt 1.75pt 4.5pt; line-height: 12.5pt"><FONT STYLE="font-size: 10pt; color: #000000"><A HREF="https://www.sec.gov/Archives/edgar/data/1022079/000094787102000692/ex4-1_040902.txt">4.4</A></FONT></TD>
    <TD STYLE="padding: 1.75pt"><FONT STYLE="color: #000000">&nbsp;</FONT></TD>
    <TD STYLE="padding: 1.75pt; text-align: justify; line-height: 12.5pt"><FONT STYLE="font-size: 10pt; color: #000000"><A HREF="https://www.sec.gov/Archives/edgar/data/1022079/000094787102000692/ex4-1_040902.txt">Third Supplemental Indenture, dated as of April 4, 2002, among the Company, the Additional Subsidiary Guarantors, and The Bank of New York (filed as an Exhibit to the Company&#8217;s current report on Form 8-K (Date of Report: April 1, 2002) and incorporated herein by reference)</A></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 1.75pt 1.75pt 1.75pt 4.5pt; line-height: 12.5pt"><FONT STYLE="font-size: 10pt; color: #000000"><A HREF="https://www.sec.gov/Archives/edgar/data/1022079/000095011703001797/ex10-1.txt">4.5</A></FONT></TD>
    <TD STYLE="padding: 1.75pt"><FONT STYLE="color: #000000">&nbsp;</FONT></TD>
    <TD STYLE="padding: 1.75pt; text-align: justify; line-height: 12.5pt"><FONT STYLE="font-size: 10pt; color: #000000"><A HREF="https://www.sec.gov/Archives/edgar/data/1022079/000095011703001797/ex10-1.txt">Fourth Supplemental Indenture dated as of March 19, 2003, among Unilab Corporation (f/k/a Quest Diagnostics Newco Incorporated), the Company, The Bank of New York, and the Additional Subsidiary Guarantors (filed as an Exhibit to the Company&#8217;s quarterly report on Form 10-Q for the quarter ended March 31, 2003 and incorporated herein by reference)</A></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 1.75pt 1.75pt 1.75pt 4.5pt; line-height: 12.5pt"><FONT STYLE="font-size: 10pt; color: #000000"><A HREF="https://www.sec.gov/Archives/edgar/data/1022079/000095011704001657/ex10-1.txt">4.6</A></FONT></TD>
    <TD STYLE="padding: 1.75pt"><FONT STYLE="color: #000000">&nbsp;</FONT></TD>
    <TD STYLE="padding: 1.75pt; text-align: justify; line-height: 12.5pt"><FONT STYLE="font-size: 10pt; color: #000000"><A HREF="https://www.sec.gov/Archives/edgar/data/1022079/000095011704001657/ex10-1.txt">Fifth Supplemental Indenture dated as of April 16, 2004, among Unilab Acquisition Corporation (d/b/a FNA Clinics of America), the Company, The Bank of New York, and the Additional Subsidiary Guarantors (filed as an Exhibit to the Company&#8217;s quarterly report on Form 10-Q for the quarter ended March 31, 2004 and incorporated herein by reference)</A></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 1.75pt 1.75pt 1.75pt 4.5pt; line-height: 12.5pt"><FONT STYLE="font-size: 10pt; color: #000000"><A HREF="https://www.sec.gov/Archives/edgar/data/1022079/000095011705004157/ex4-7.htm">4.7</A></FONT></TD>
    <TD STYLE="padding: 1.75pt"><FONT STYLE="color: #000000">&nbsp;</FONT></TD>
    <TD STYLE="padding: 1.75pt; text-align: justify; line-height: 12.5pt"><FONT STYLE="font-size: 10pt; color: #000000"><A HREF="https://www.sec.gov/Archives/edgar/data/1022079/000095011705004157/ex4-7.htm">Sixth Supplemental Indenture dated as of October 31, 2005, among the Company, The Bank of New York, and the Subsidiary Guarantors (filed as an Exhibit to the Company&#8217;s current report on Form 8-K (Date of Report: October 31, 2005) and incorporated herein by reference)</A></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 1.75pt 1.75pt 1.75pt 4.5pt; line-height: 12.5pt"><FONT STYLE="font-size: 10pt; color: #000000"><A HREF="https://www.sec.gov/Archives/edgar/data/1022079/000095011705004480/ex4-1.htm">4.8</A></FONT></TD>
    <TD STYLE="padding: 1.75pt"><FONT STYLE="color: #000000">&nbsp;</FONT></TD>
    <TD STYLE="padding: 1.75pt; text-align: justify; line-height: 12.5pt"><FONT STYLE="font-size: 10pt; color: #000000"><A HREF="https://www.sec.gov/Archives/edgar/data/1022079/000095011705004480/ex4-1.htm">Seventh Supplemental Indenture dated as of November 21, 2005, among the Company, The Bank of New York, and the Additional Subsidiary Guarantors (filed as an Exhibit to the Company&#8217;s current report on Form 8-K (Date of Report: November 21, 2005) and incorporated herein by reference)</A></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 1.75pt 1.75pt 1.75pt 4.5pt; line-height: 12.5pt"><FONT STYLE="font-size: 10pt; color: #000000"><A HREF="https://www.sec.gov/Archives/edgar/data/1022079/000095011706003285/ex4-1.htm">4.9</A></FONT></TD>
    <TD STYLE="padding: 1.75pt"><FONT STYLE="color: #000000">&nbsp;</FONT></TD>
    <TD STYLE="padding: 1.75pt; text-align: justify; line-height: 12.5pt"><FONT STYLE="font-size: 10pt; color: #000000"><A HREF="https://www.sec.gov/Archives/edgar/data/1022079/000095011706003285/ex4-1.htm">Eighth Supplemental Indenture dated as of July 31, 2006, among the Company, The Bank of New York, and the Additional Subsidiary Guarantors (filed as an Exhibit to the Company&#8217;s current report on Form 8-K (Date of Report: July 31, 2006) and incorporated herein by reference)</A></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 1.75pt 1.75pt 1.75pt 4.5pt; line-height: 12.5pt"><FONT STYLE="font-size: 10pt; color: #000000"><A HREF="https://www.sec.gov/Archives/edgar/data/1022079/000095011706004130/ex4-1.htm">4.10</A></FONT></TD>
    <TD STYLE="padding: 1.75pt"><FONT STYLE="color: #000000">&nbsp;</FONT></TD>
    <TD STYLE="padding: 1.75pt; text-align: justify; line-height: 12.5pt"><FONT STYLE="font-size: 10pt; color: #000000"><A HREF="https://www.sec.gov/Archives/edgar/data/1022079/000095011706004130/ex4-1.htm">Ninth Supplemental Indenture dated as of September 30, 2006, among the Company, The Bank of New York, and the Additional Subsidiary Guarantors (filed as an Exhibit to the Company&#8217;s current report on Form 8-K (Date of Report: September 30, 2006) and incorporated herein by reference)</A></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 1.75pt 1.75pt 1.75pt 4.5pt; line-height: 12.5pt"><FONT STYLE="font-size: 10pt; color: #000000"><A HREF="https://www.sec.gov/Archives/edgar/data/1022079/000093041307005477/c49146_ex4-11.htm">4.11</A></FONT></TD>
    <TD STYLE="padding: 1.75pt"><FONT STYLE="color: #000000">&nbsp;</FONT></TD>
    <TD STYLE="padding: 1.75pt; text-align: justify; line-height: 12.5pt"><FONT STYLE="font-size: 10pt; color: #000000"><A HREF="https://www.sec.gov/Archives/edgar/data/1022079/000093041307005477/c49146_ex4-11.htm">Tenth Supplemental Indenture dated as of June 22, 2007, among the Company, The Bank of New York, and the Subsidiary Guarantors (filed as an Exhibit to the Company&#8217;s current report on Form 8-K (Date of Report: June 19, 2007) and incorporated herein by reference)</A></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 1.75pt 1.75pt 1.75pt 4.5pt; line-height: 12.5pt"><FONT STYLE="font-size: 10pt; color: #000000"><A HREF="https://www.sec.gov/Archives/edgar/data/1022079/000093041307005477/c49146_ex4-14.htm">4.12</A></FONT></TD>
    <TD STYLE="padding: 1.75pt"><FONT STYLE="color: #000000">&nbsp;</FONT></TD>
    <TD STYLE="padding: 1.75pt; text-align: justify; line-height: 12.5pt"><FONT STYLE="font-size: 10pt; color: #000000"><A HREF="https://www.sec.gov/Archives/edgar/data/1022079/000093041307005477/c49146_ex4-14.htm">Eleventh Supplemental Indenture dated as of June 22, 2007, among the Company, The Bank of New York, and the Additional Subsidiary Guarantors (filed as an Exhibit to the Company&#8217;s current report on Form 8-K (Date of Report: June 19, 2007) and incorporated herein by reference)</A></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; width: 100%"><TR><TD STYLE="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD COLSPAN="2" STYLE="vertical-align: top; padding: 1.75pt 1.75pt 1.75pt 4.5pt; line-height: 12.5pt"><FONT STYLE="font-size: 10pt; color: #000000"><A HREF="https://www.sec.gov/Archives/edgar/data/1022079/000093041307005477/c49146_ex4-15.htm">4.13</A></FONT></TD>
    <TD STYLE="vertical-align: top; padding: 1.75pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: top; padding: 1.75pt; text-align: justify; line-height: 12.5pt"><FONT STYLE="font-size: 10pt; color: #000000"><A HREF="https://www.sec.gov/Archives/edgar/data/1022079/000093041307005477/c49146_ex4-15.htm">Twelfth Supplemental Indenture dated as of June 25, 2007, among the Company, The Bank of New York, and the Additional Subsidiary Guarantors (filed as an Exhibit to the Company&#8217;s current report on Form 8-K (Date of Report: June 19, 2007) and incorporated herein by reference)</A></FONT></TD></TR>
  <TR>
    <TD COLSPAN="2" STYLE="vertical-align: top; padding: 1.75pt 1.75pt 1.75pt 4.5pt; line-height: 12.5pt"><FONT STYLE="font-size: 10pt; color: #000000"><A HREF="https://www.sec.gov/Archives/edgar/data/1022079/000093041309005838/c59427_ex4-14.htm">4.14</A></FONT></TD>
    <TD STYLE="vertical-align: top; padding: 1.75pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: top; padding: 1.75pt; text-align: justify; line-height: 12.5pt"><FONT STYLE="font-size: 10pt; color: #000000"><A HREF="https://www.sec.gov/Archives/edgar/data/1022079/000093041309005838/c59427_ex4-14.htm">Thirteenth Supplemental Indenture dated as of November 17, 2009, among the Company, The Bank of New York Mellon, and the Subsidiary Guarantors (filed as an Exhibit to the Company&#8217;s current report on Form 8-K (Date of Report: November 17, 2009) and incorporated herein by reference)</A></FONT></TD></TR>
  <TR>
    <TD COLSPAN="2" STYLE="vertical-align: top; padding: 1.75pt 1.75pt 1.75pt 4.5pt; line-height: 12.5pt"><FONT STYLE="font-size: 10pt; color: #000000"><A HREF="https://www.sec.gov/Archives/edgar/data/1022079/000093041311002247/c64911_ex4-15.htm">4.15</A></FONT></TD>
    <TD STYLE="vertical-align: top; padding: 1.75pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: top; padding: 1.75pt; text-align: justify; line-height: 12.5pt"><FONT STYLE="font-size: 10pt; color: #000000"><A HREF="https://www.sec.gov/Archives/edgar/data/1022079/000093041311002247/c64911_ex4-15.htm">Fourteenth Supplemental Indenture dated as of March 24, 2011, among the Company, The Bank of New York Mellon, and the Subsidiary Guarantors (filed as an Exhibit to the Company&#8217;s current report on Form 8-K (Date of Report: March 21, 2011) and incorporated herein by reference)</A></FONT></TD></TR>
  <TR>
    <TD COLSPAN="2" STYLE="vertical-align: top; padding: 1.75pt 1.75pt 1.75pt 4.5pt; line-height: 12.5pt"><FONT STYLE="font-size: 10pt; color: #000000"><A HREF="https://www.sec.gov/Archives/edgar/data/1022079/000093041312000949/c68209_ex4-24.htm">4.16</A></FONT></TD>
    <TD STYLE="vertical-align: top; padding: 1.75pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: top; padding: 1.75pt; text-align: justify; line-height: 12.5pt"><FONT STYLE="font-size: 10pt; color: #000000"><A HREF="https://www.sec.gov/Archives/edgar/data/1022079/000093041312000949/c68209_ex4-24.htm">Fifteenth Supplemental Indenture dated as of November 30, 2011, among the Company, The Bank of New York Mellon, and the Additional Subsidiary Guarantors (filed as an Exhibit to the Company&#8217;s 2011 annual report on Form 10-K and incorporated herein by reference)</A></FONT></TD></TR>
  <TR>
    <TD COLSPAN="2" STYLE="vertical-align: top; padding: 1.75pt 1.75pt 1.75pt 4.5pt; line-height: 12.5pt"><FONT STYLE="font-size: 10pt; color: #000000"><A HREF="https://www.sec.gov/Archives/edgar/data/1022079/000094787114000160/ss206544_ex0417.htm">4.17</A></FONT></TD>
    <TD STYLE="vertical-align: top; padding: 1.75pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: top; padding: 1.75pt; text-align: justify; line-height: 12.5pt"><FONT STYLE="font-size: 10pt; color: #000000"><A HREF="https://www.sec.gov/Archives/edgar/data/1022079/000094787114000160/ss206544_ex0417.htm">Sixteenth Supplemental Indenture dated as of March 17, 2014, between the Company and The Bank of New York Mellon (filed as an Exhibit to the Company&#8217;s current report on Form 8-K (Date of Report: March 12, 2014) and incorporated herein by reference)</A></FONT></TD></TR>
  <TR>
    <TD COLSPAN="2" STYLE="vertical-align: top; padding: 1.75pt 1.75pt 1.75pt 4.5pt; line-height: 12.5pt"><FONT STYLE="font-size: 10pt; color: #000000"><A HREF="https://www.sec.gov/Archives/edgar/data/1022079/000094787115000168/ss419933_ex0418.htm">4.18</A></FONT></TD>
    <TD STYLE="vertical-align: top; padding: 1.75pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: top; padding: 1.75pt; text-align: justify; line-height: 12.5pt"><FONT STYLE="font-size: 10pt; color: #000000"><A HREF="https://www.sec.gov/Archives/edgar/data/1022079/000094787115000168/ss419933_ex0418.htm">Seventeenth Supplemental Indenture dated as of March 10, 2015, between the Company and The Bank of New York Mellon (filed as an Exhibit to the Company&#8217;s current report on Form 8-K (Date of Report: March 5, 2015) and incorporated herein by reference)</A></FONT></TD></TR>
  <TR>
    <TD COLSPAN="2" STYLE="vertical-align: top; padding: 1.75pt 1.75pt 1.75pt 4.5pt; line-height: 12.5pt"><FONT STYLE="font-size: 10pt; color: #000000"><A HREF="https://www.sec.gov/Archives/edgar/data/1022079/000094787116001220/ss1485098_ex0419.htm">4.19</A></FONT></TD>
    <TD STYLE="vertical-align: top; padding: 1.75pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: top; padding: 1.75pt; text-align: justify; line-height: 12.5pt"><FONT STYLE="font-size: 10pt; color: #000000"><A HREF="https://www.sec.gov/Archives/edgar/data/1022079/000094787116001220/ss1485098_ex0419.htm">Eighteenth Supplemental Indenture dated as of May 26, 2016, between the Company and The Bank of New York Mellon (filed as an Exhibit to the Company&#8217;s current report on Form 8-K (Date of Report: May 23, 2016) and incorporated herein by reference)</A></FONT></TD></TR>
  <TR>
    <TD COLSPAN="2" STYLE="vertical-align: top; padding: 1.75pt 1.75pt 1.75pt 4.5pt; line-height: 12.5pt"><FONT STYLE="font-size: 10pt; color: #000000"><A HREF="https://www.sec.gov/Archives/edgar/data/1022079/000094787119000202/ss128814_ex0402.htm">4.20</A></FONT></TD>
    <TD STYLE="vertical-align: top; padding: 1.75pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: top; padding: 1.75pt; text-align: justify; line-height: 12.5pt"><FONT STYLE="font-size: 10pt; color: #000000"><A HREF="https://www.sec.gov/Archives/edgar/data/1022079/000094787119000202/ss128814_ex0402.htm">Nineteenth Supplemental Indenture dated as of March 12 2019, between the Company and The Bank of New York Mellon (filed as an Exhibit to the Company&#8217;s current report on Form 8-K (Date of Report: March 7, 2019) and incorporated herein by reference)</A></FONT></TD></TR>
  <TR>
    <TD COLSPAN="2" STYLE="vertical-align: top; padding: 1.75pt 1.75pt 1.75pt 4.5pt; line-height: 12.5pt"><FONT STYLE="font-size: 10pt; color: #000000"><A HREF="https://www.sec.gov/Archives/edgar/data/1022079/000094787119000973/ss160605_ex0402.htm">4.21</A></FONT></TD>
    <TD STYLE="vertical-align: top; padding: 1.75pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: top; padding: 1.75pt; text-align: justify; line-height: 12.5pt"><FONT STYLE="font-size: 10pt; color: #000000"><A HREF="https://www.sec.gov/Archives/edgar/data/1022079/000094787119000973/ss160605_ex0402.htm">Twentieth Supplemental Indenture dated as of December 16, 2019, between the Company and The Bank of New York Mellon (filed as an Exhibit to the Company&#8217;s current report on Form 8-K (Date of Report: December 16, 2019) and incorporated herein by reference)</A></FONT></TD></TR>
  <TR>
    <TD COLSPAN="2" STYLE="vertical-align: top; padding: 1.75pt 1.75pt 1.75pt 4.5pt; line-height: 12.5pt"><FONT STYLE="font-size: 10pt; color: #000000"><A HREF="https://www.sec.gov/Archives/edgar/data/1022079/000094787120000458/ss173511_ex0402.htm">4.22</A></FONT></TD>
    <TD STYLE="vertical-align: top; padding: 1.75pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding: 1.75pt; text-align: justify; line-height: 12.5pt"><FONT STYLE="font-size: 10pt; color: #000000"><A HREF="https://www.sec.gov/Archives/edgar/data/1022079/000094787120000458/ss173511_ex0402.htm">Twenty-First Supplemental Indenture dated as of May 13, 2020, between the Company and The Bank of New York Mellon (filed as an Exhibit to the Company&#8217;s current report on Form 8-K (Date of Report: May 11, 2020) and incorporated herein by reference)</A></FONT></TD></TR>
  <TR>
    <TD COLSPAN="2" STYLE="vertical-align: top; padding: 1.75pt 1.75pt 1.75pt 4.5pt; line-height: 12.5pt"><FONT STYLE="font-size: 10pt; color: #000000"><A HREF="https://www.sec.gov/Archives/edgar/data/1022079/000102207923000172/dgx10302023ex42.htm">4.23</A></FONT></TD>
    <TD STYLE="vertical-align: top; padding: 1.75pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding: 1.75pt; text-align: justify; line-height: 12.5pt"><FONT STYLE="font-size: 10pt; color: #000000"><A HREF="https://www.sec.gov/Archives/edgar/data/1022079/000102207923000172/dgx10302023ex42.htm">Twenty-Second Supplemental Indenture dated as of November 1, 2023, between the Company and The Bank of New York Mellon (filed as an Exhibit to the Company&#8217;s current report on Form 8-K (Date of Report: October 30, 2023) and incorporated herein by reference)</A></FONT></TD></TR>
  <TR>
    <TD COLSPAN="2" STYLE="vertical-align: top; padding: 1.75pt 1.75pt 1.75pt 4.5pt; line-height: 12.5pt"><FONT STYLE="font-size: 10pt; color: #000000"><A HREF="https://www.sec.gov/Archives/edgar/data/1022079/000110465924090867/tm2421254d4_ex4-2.htm">4.24</A></FONT></TD>
    <TD STYLE="vertical-align: top; padding: 1.75pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding: 1.75pt; text-align: justify; line-height: 12.5pt"><FONT STYLE="font-size: 10pt; color: #000000"><A HREF="https://www.sec.gov/Archives/edgar/data/1022079/000110465924090867/tm2421254d4_ex4-2.htm">Twenty-Third Supplemental Indenture dated as of August 19, 2024, between the Company and The Bank of New York Mellon (filed as an Exhibit to the Company&#8217;s current report on Form 8-K (Date of Report: August 14, 2024) and incorporated herein by reference)</A></FONT></TD></TR>
  <TR>
    <TD COLSPAN="2" STYLE="vertical-align: top; padding: 1.75pt; line-height: 12.5pt"><FONT STYLE="font-size: 10pt; color: #000000"><A HREF="ss4963221_ex0501.htm">&#8224;5.1</A></FONT></TD>
    <TD STYLE="vertical-align: top; padding: 1.75pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: top; padding: 1.75pt; text-align: justify; line-height: 12.5pt"><FONT STYLE="font-size: 10pt; color: #000000"><A HREF="ss4963221_ex0501.htm">Opinion of Allen Overy Shearman Sterling US LLP</A></FONT></TD></TR>
  <TR>
    <TD COLSPAN="2" STYLE="vertical-align: top; padding: 1.75pt; line-height: 12.5pt"><FONT STYLE="font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1022079/000102207925000120/dgx03312025ex22.htm">22.1</A></FONT></TD>
    <TD STYLE="vertical-align: top; padding: 1.75pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: top; padding: 1.75pt; text-align: justify; line-height: 12.5pt"><FONT STYLE="font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1022079/000102207925000120/dgx03312025ex22.htm">Subsidiary Guarantors of Securities (filed as an Exhibit to the Company&#8217;s quarterly report on Form 10-Q for the quarter ended March 31, 2025 and incorporated herein by reference)</A></FONT></TD></TR>
  <TR>
    <TD COLSPAN="2" STYLE="vertical-align: top; padding: 1.75pt; line-height: 12.5pt"><FONT STYLE="font-size: 10pt; color: #000000"><A HREF="ss4963221_ex0501.htm">&#8224;23.1</A></FONT></TD>
    <TD STYLE="vertical-align: top; padding: 1.75pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: top; padding: 1.75pt; text-align: justify; line-height: 12.5pt"><FONT STYLE="font-size: 10pt; color: #000000"><A HREF="ss4963221_ex0501.htm">Consent of Allen Overy Shearman Sterling US LLP (included in Exhibit 5.1)</A></FONT></TD></TR>
  <TR>
    <TD COLSPAN="2" STYLE="vertical-align: top; padding: 1.75pt; line-height: 12.5pt"><FONT STYLE="font-size: 10pt; color: #000000"><A HREF="ss4963221_ex2302.htm">&#8224;23.2</A></FONT></TD>
    <TD STYLE="vertical-align: top; padding: 1.75pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: top; padding: 1.75pt; text-align: justify; line-height: 12.5pt"><FONT STYLE="font-size: 10pt; color: #000000"><A HREF="ss4963221_ex2302.htm">Consent of PricewaterhouseCoopers LLP as Independent Registered Public Accounting Firm for Quest Diagnostics Incorporated</A></FONT></TD></TR>
  <TR>
    <TD COLSPAN="2" STYLE="vertical-align: top; padding: 1.75pt; line-height: 12.5pt"><FONT STYLE="font-size: 10pt; color: #000000"><A HREF="#a_012">24.1</A></FONT></TD>
    <TD STYLE="vertical-align: top; padding: 1.75pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: top; padding: 1.75pt; text-align: justify; line-height: 12.5pt"><FONT STYLE="font-size: 10pt; color: #000000"><A HREF="#a_012">Powers of Attorney (included in signature pages)</A></FONT></TD></TR>
  <TR>
    <TD COLSPAN="2" STYLE="vertical-align: top; padding: 1.75pt; line-height: 12.5pt"><FONT STYLE="font-size: 10pt; color: Navy"><A HREF="ss4963221_ex2501.htm">&#8224;25.1</A></FONT></TD>
    <TD STYLE="vertical-align: top; padding: 1.75pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: top; padding: 1.75pt; text-align: justify; line-height: 12.5pt"><FONT STYLE="font-size: 10pt; color: Navy"><A HREF="ss4963221_ex2501.htm">Form T-1 Statement of Eligibility of The Bank of New York Mellon, as trustee with respect to the indenture dated as of June 27, 2001</A></FONT></TD></TR>
  <TR>
    <TD COLSPAN="2" STYLE="vertical-align: top; padding: 1.75pt; line-height: 12.5pt"><FONT STYLE="font-size: 10pt; color: #000000"><A HREF="ss4963221_ex107.htm">&nbsp;&#8224;107</A></FONT></TD>
    <TD STYLE="vertical-align: top; padding: 1.75pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: top; padding: 1.75pt; text-align: justify; line-height: 12.5pt"><FONT STYLE="font-size: 10pt; color: #000000"><A HREF="ss4963221_ex107.htm">Filing Fee Table</A></FONT></TD></TR>
  <TR>
    <TD STYLE="width: 3%"><FONT STYLE="font-size: 2pt; color: #000000">&nbsp;</FONT></TD>
    <TD STYLE="width: 11%"><FONT STYLE="font-size: 2pt; color: #000000">&nbsp;</FONT></TD>
    <TD STYLE="width: 2%"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 83%"><FONT STYLE="font-size: 2pt; color: #000000">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%"></TD></TR>
  </TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">*</FONT></TD>
    <TD COLSPAN="3" STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Executed versions of this document will, if applicable, be filed by current report on Form 8-K after the issuance of the securities to which it relates.</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">&#8224;</FONT></TD>
    <TD COLSPAN="3" STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Filed herewith.</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 11%">&nbsp;</TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 83%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 10pt 0 0"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; width: 100%"><TR><TD STYLE="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 10pt 0 0"><B>Item 17. Undertakings</B>.<BR>
<BR>
</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0">(a) The undersigned registrant hereby undertakes:</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(1)</TD><TD>to file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD>to include any prospectus required by Section 10(a)(3) of the Securities Act of 1933;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD>to reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent
post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth
in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of debt securities offered (if the total
dollar value of debt securities offered would not exceed that which was registered) and any deviation from the low or high end of the
estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the
aggregate, the changes in volume and price represent no more than a 20% change in the maximum aggregate offering price set forth in the
&#8220;Calculation of Registration Fee&#8221; table in the effective registration statement; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(iii)</TD><TD>to include any material information with respect to the plan of distribution not previously disclosed in the registration statement
or any material change to such information in the registration statement;</TD></TR></TABLE>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0"><I>provided, however</I>, that paragraphs (1)(i), (1)(ii) and (1)(iii)
above do not apply if information required to be included in a post-effective amendment by those paragraphs is contained in periodic reports
filed with or furnished to the Commission by the registrant pursuant to Section 13 or Section 15(d) of the Exchange Act that are incorporated
by reference in the registration statement, or is contained in a form of prospectus filed pursuant to Rule 424(b) that is part of the
registration statement;</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(2)</TD><TD>that, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed
to be a new registration statement relating to the debt securities offered therein, and the offering of such debt securities at that time
shall be deemed to be the initial bona fide offering thereof;<BR>
<BR>
</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(3)</TD><TD>to remove from registration by means of a post-effective amendment any of the debt securities being registered which remain unsold
at the termination of the offering;<BR>
<BR>
</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(4)</TD><TD>that, for the purpose of determining any liability under the Securities Act of 1933 to any purchaser:</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD>each prospectus filed by the registrant pursuant to Rule 424(b)(3) shall be deemed to be part of the registration statement as of
the date the filed prospectus was deemed part of and included in the registration statement; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD>each prospectus required to be filed pursuant to Rule 424(b)(2), (b)(5) or (b)(7) as part of a registration statement in reliance
on Rule 430B relating to an offering made pursuant to Rule 415(a)(1)(i), (vii) or (x) for the purpose of providing the information required
by Section 10(a) of the Securities Act of 1933 shall be deemed to be part of and included in the registration statement as of the earlier
of the date such form of prospectus is first used after effectiveness or the date of the first contract of sale of debt securities in
the offering described in the prospectus. As provided in Rule 430B, for liability purposes of the issuer and any person that is at that
date an underwriter, such date shall be deemed to be a new effective date of the registration statement relating to the debt securities
in the registration statement to which that prospectus relates, and the offering of such debt securities at that time shall be deemed
to be the initial bona fide offering thereof; provided, however, that no statement made in a registration statement or prospectus that
is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement
or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such effective
date, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement
or made in any such document immediately prior to such effective date;</TD></TR></TABLE>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; width: 100%"><TR><TD STYLE="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(5)</TD><TD>that, for the purpose of determining liability of a registrant under the Securities Act of 1933 to any purchaser in the initial distribution
of the debt securities, the undersigned registrant undertakes that in a primary offering of debt securities of the undersigned registrant
pursuant to this registration statement, regardless of the underwriting method used to sell the debt securities to the purchaser, if the
debt securities are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will
be a seller to the purchaser and will be considered to offer or sell such debt securities to such purchaser:</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD>any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule
424;&#9;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD>any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to
by the undersigned registrant;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(iii)</TD><TD>the portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant
or its debt securities provided by or on behalf of the undersigned registrant; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(iv)</TD><TD>any other communication that is an offer in the offering made by the undersigned registrant to the purchaser.<BR>
<BR>
</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(b)</TD><TD>The undersigned registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing
of the registrant&#8217;s annual report pursuant to Section 13(a) or Section 15(d) of the Exchange Act (and, where applicable, each filing
of an employee benefit plan&#8217;s annual report pursuant to Section 15(d) of the Exchange Act) that is incorporated by reference in
the registration statement shall be deemed to be a new registration statement relating to the debt securities offered therein, and the
offering of such debt securities at that time shall be deemed to be the initial bona fide offering thereof.<BR>
<BR>
</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(c)</TD><TD>Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling
persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the
SEC such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that
a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director,
officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director,
officer or controlling person in connection with the debt securities being registered, the registrant will, unless in the opinion of its
counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question of whether such
indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such
issue.</TD></TR></TABLE>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; width: 100%"><TR><TD STYLE="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
of the Securities Act of 1933, as amended, the registrant certifies that it has reasonable grounds to believe that it meets all of the
requirements for filing on Form S-3 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto
duly authorized, in the City of Secaucus, State of New Jersey, on June 20, 2025.</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>QUEST DIAGNOSTICS INCORPORATED</B></FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 44%">&nbsp;</TD>
    <TD STYLE="width: 3%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-size: 10pt">By: </FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 0.75pt"><FONT STYLE="font-size: 10pt">&nbsp;/s/ James E. Davis</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">James E. Davis</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="white-space: nowrap">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Title: Chairman, Chief Executive Officer and President</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>

<P STYLE="text-indent: 0.5in; font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Pursuant to the requirements of the Securities
Act of 1933, this registration statement has been signed on June 20, 2025 by the following persons in the capacities and on the dates
indicated.</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><A NAME="a_012" TITLE="powerofattorney"></A>POWER OF ATTORNEY</B></P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Each individual whose manual
signature appears below constitutes and appoints Michael E. Prevoznik and Sean D. Mersten, and each of them singly, his or her true and
lawful attorneys-in-fact and agents with full power of substitution, for him or her and in his or her name, place and stead, in any and
all capacities, to sign this registration statement and any and all amendments thereto, including post-effective amendments, and to file
the same, with all exhibits thereto, any related registration filed pursuant to Rule 462(b) under the Securities Act of 1933, as amended,
and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents,
and each of them full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about
the premises, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all the said
attorneys-in-fact and agents or any of them or their or his or her substitutes, may lawfully do or cause to be done by virtue hereof.</P>

<P STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; width: 25%; font: 10pt/12.5pt Times New Roman, Times, Serif; padding: 0.25pt 0.25pt 0.75pt"><FONT STYLE="font-size: 10pt"><B>Signature</B></FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 1%; padding: 0.25pt 0.25pt 0.75pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 74%; font: 10pt/12.5pt Times New Roman, Times, Serif; padding: 0.25pt 0.25pt 0.75pt"><FONT STYLE="font-size: 10pt"><B>Title</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.75pt 0.25pt 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.75pt 0.25pt 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0.25pt 0.25pt 0.75pt"><FONT STYLE="font-size: 10pt">/s/ James E. Davis</FONT></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; padding: 0.25pt"><FONT STYLE="font-size: 10pt">Chairman, Chief Executive Officer and President</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; padding: 0.75pt 0.25pt 0.25pt 0.1in"><FONT STYLE="font-size: 10pt">James E. Davis</FONT></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0.25pt 0.25pt 0.75pt"><FONT STYLE="font-size: 10pt">/s/ Sam A. Samad</FONT></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; padding: 0.25pt"><FONT STYLE="font-size: 10pt">Executive Vice President and Chief Financial Officer</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; padding: 0.75pt 0.25pt 0.25pt 0.1in"><FONT STYLE="font-size: 10pt">Sam A. Samad</FONT></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0.25pt 0.25pt 0.75pt"><FONT STYLE="font-size: 10pt">/s/ Michael J. Deppe</FONT></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; padding: 0.25pt"><FONT STYLE="font-size: 10pt">Senior Vice President, Corporate Controller and Chief Accounting Officer</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; padding: 0.75pt 0.25pt 0.25pt 0.1in"><FONT STYLE="font-size: 10pt">Michael J. Deppe</FONT></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0.25pt 0.25pt 0.75pt"><FONT STYLE="font-size: 10pt">/s/ Robert B. Carter</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; padding: 0.25pt"><FONT STYLE="font-size: 10pt">Director</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.25pt 0.25pt 0.75pt"><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;Robert B. Carter<BR>
<BR>
</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; padding: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0.25pt 0.25pt 0.75pt"><FONT STYLE="font-size: 10pt">/s/ Luis A. Diaz, Jr.</FONT></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; padding: 0.25pt"><FONT STYLE="font-size: 10pt">Director</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; padding: 0.75pt 0.25pt 0.25pt 0.1in"><FONT STYLE="font-size: 10pt">Luis A. Diaz, Jr.</FONT></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0.25pt 0.25pt 0.75pt"><FONT STYLE="font-size: 10pt">/s/ Tracey C. Doi</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; padding: 0.25pt"><FONT STYLE="font-size: 10pt">Director</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt 0.25pt 0.75pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Tracey C. Doi</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; padding: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0.25pt 0.25pt 0.75pt"><FONT STYLE="font-size: 10pt">/s/ Vicky B. Gregg</FONT></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; padding: 0.25pt"><FONT STYLE="font-size: 10pt">Director</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; padding: 0.75pt 0.25pt 0.25pt 0.1in"><FONT STYLE="font-size: 10pt">Vicky B. Gregg</FONT></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0.25pt 0.25pt 0.75pt"><FONT STYLE="font-size: 10pt">/s/ Wright L. Lassiter, III</FONT></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; padding: 0.25pt"><FONT STYLE="font-size: 10pt">Director</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; padding: 0.75pt 0.25pt 0.25pt 0.1in"><FONT STYLE="font-size: 10pt">Wright L. Lassiter, III</FONT></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0.25pt 0.25pt 0.75pt"><FONT STYLE="font-size: 10pt">/s/ Timothy L. Main</FONT></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; padding: 0.25pt"><FONT STYLE="font-size: 10pt">Director</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; padding: 0.75pt 0.25pt 0.25pt 0.1in"><FONT STYLE="font-size: 10pt">Timothy L. Main</FONT></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 22; Options: NewSection -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; width: 100%"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 25%; padding: 0.25pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; padding: 0.25pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 74%; padding: 0.25pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0.25pt 0.25pt 0.75pt"><FONT STYLE="font-size: 10pt">/s/ Denise M. Morrison</FONT></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; padding: 0.25pt"><FONT STYLE="font-size: 10pt">Director</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; padding: 0.75pt 0.25pt 0.25pt 0.1in"><FONT STYLE="font-size: 10pt">Denise M. Morrison</FONT></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0.25pt 0.25pt 0.75pt"><FONT STYLE="font-size: 10pt">/s/ Gary M. Pfeiffer</FONT></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; padding: 0.25pt"><FONT STYLE="font-size: 10pt">Director</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; padding: 0.75pt 0.25pt 0.25pt 0.1in"><FONT STYLE="font-size: 10pt">Gary M. Pfeiffer</FONT></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; padding: 0.75pt 0.25pt 0.25pt 0.1in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0.25pt 0.25pt 0.75pt"><FONT STYLE="font-size: 10pt">/s/ Timothy M. Ring</FONT></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; padding: 0.25pt"><FONT STYLE="font-size: 10pt">Director</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 10pt/12.5pt Times New Roman, Times, Serif; padding: 0.75pt 0.25pt 0.25pt 0.1in"><FONT STYLE="font-size: 10pt">Timothy M. Ring</FONT></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">2</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>ss4963221_ex0501.htm
<DESCRIPTION>OPINION OF ALLEN OVERY SHEARMAN STERLING US LLP
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 5.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 12pt/normal Times New Roman, Times, Serif; width: 100%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><P STYLE="margin-top: 0; margin-bottom: 0"><IMG SRC="image_001.jpg" ALT=""></P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">
    <P STYLE="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><FONT STYLE="letter-spacing: 0.5pt">599 Lexington Avenue<BR>
    New York, NY 10022-6069</FONT></P>
    <P STYLE="font: 7pt Arial Narrow, Helvetica, Sans-Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase; letter-spacing: 0.5pt">&nbsp;</FONT></P>
    <P STYLE="font: 7pt Arial Narrow, Helvetica, Sans-Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase; letter-spacing: 0.5pt">&nbsp;</FONT></P>
    <P STYLE="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase; letter-spacing: 0.5pt">+1.212.848.4000</FONT></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: right">June 20, 2025</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">The Board of Directors</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">Quest Diagnostics Incorporated</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">500 Plaza Drive</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">Secaucus, NJ 07094</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">Quest Diagnostics Incorporated</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><U>Registration Statement on Form S-3</U></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">Ladies and Gentlemen:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">We have acted as counsel to Quest Diagnostics Incorporated, a Delaware
corporation (the &#8220;<U>Company</U>&#8221;), in connection with the preparation and filing by the Company of a registration statement
on Form S-3 (the &#8220;<U>Registration Statement</U>&#8221;) filed with the Securities and Exchange Commission relating to the offering
from time to time, pursuant to Rule 415 of the Securities Act of 1933, as amended (the &#8220;<U>Securities Act</U>&#8221;), of one or
more series of debt securities of the Company (the &#8220;<U>Debt Securities</U>&#8221;). The offering of the Debt Securities will be
as set forth in the prospectus contained in the Registration Statement (the &#8220;<U>Prospectus</U>&#8221;), as supplemented by one or
more supplements to the Prospectus.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">The Debt Securities will be issued in one or more series pursuant to an
indenture, dated as of June 27, 2001, among the Company, the Subsidiary Guarantors (as defined therein) party thereto and The Bank of
New York Mellon, formerly known as The Bank of New York, as trustee (the &#8220;<U>Trustee</U>&#8221;), as supplemented by the first supplemental
indenture, dated as of June 27, 2001, among the Company, the Initial Subsidiary Guarantors (as defined therein) party thereto as guarantors,
and the Trustee, as further supplemented by the second supplemental indenture, dated as of November 26, 2001, among the Company, the Subsidiary
Guarantors (as defined therein) party thereto and the Trustee, as further supplemented by the third supplemental indenture, dated as of
April 4, 2002, among the Company, the Additional Subsidiary Guarantors (as defined therein) party thereto and the Trustee, as further
supplemented by the fourth supplemental indenture, dated as of March 19, 2003, among the Company, the Additional Subsidiary Guarantor
(as defined therein) party thereto and the Trustee, as further supplemented by the fifth supplemental indenture, dated as of April 16,
2004, among the Company, the Additional Subsidiary Guarantors (as defined therein) party thereto and the Trustee, as further supplemented
by the sixth supplemental indenture, dated as of October 31, 2005, among the Company,</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 3pt; width: 100%; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Arial Narrow, Helvetica, Sans-Serif; font-size: 9.5pt"><B>AOSHEARMAN.COM</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 12pt/8pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Arial Narrow, Helvetica, Sans-Serif; font-size: 6pt">Allen Overy Shearman Sterling US LLP is a limited liability partnership organized under the laws of the State of Delaware. Allen Overy Shearman Sterling US LLP is affiliated with Allen Overy Shearman Sterling LLP, a limited liability partnership registered in England and Wales with registered number OC306763 and with its registered office at One Bishops Square, London E1 6AD.&nbsp;&nbsp;It is authorized and regulated by the Solicitors Regulation Authority of England and Wales (SRA number 401323).&nbsp;&nbsp;The term partner is used to refer to a member of Allen Overy Shearman Sterling LLP or an employee or consultant with equivalent standing and qualifications.&nbsp;&nbsp;A list of the members of Allen Overy Shearman Sterling LLP and of the non-members who are designated as partners is open to inspection at its registered office at One Bishops Square, London E1 6AD. </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">the Subsidiary Guarantors (as defined therein) party thereto and the Trustee,
as further supplemented by the seventh supplemental indenture, dated as of November 21, 2005, among the Company, the Additional Subsidiary
Guarantors (as defined therein) party thereto and the Trustee, as further supplemented by the eighth supplemental indenture, dated as
of July 31, 2006, among the Company, the Additional Subsidiary Guarantors (as defined therein) party thereto and the Trustee, as further
supplemented by the ninth supplemental indenture, dated as of September 30, 2006, among the Company, the Additional Subsidiary Guarantors
(as defined therein) party thereto and the Trustee, as further supplemented by the tenth supplemental indenture, dated as of June 22,
2007, among the Company, the Subsidiary Guarantors (as defined therein) party thereto and the Trustee, as further supplemented by the
eleventh supplemental indenture, dated as of June 22, 2007, among the Company, the Additional Subsidiary Guarantors (as defined therein)
party thereto and the Trustee, as further supplemented by the twelfth supplemental indenture, dated as of June 25, 2007, among the Company,
the Additional Subsidiary Guarantors (as defined therein) party thereto and the Trustee, as further supplemented by the thirteenth supplemental
indenture, dated as of November 17, 2009, among the Company, the Subsidiary Guarantors (as defined therein) party thereto and the Trustee,
as further supplemented by the fourteenth supplemental indenture, dated as of March 24, 2011, among the Company, the Subsidiary Guarantors
(as defined therein) party thereto and the Trustee, as further supplemented by the fifteenth supplemental indenture, dated as of November
30, 2011, among the Company, the Additional Subsidiary Guarantors (as defined therein) party thereto and the Trustee, as further supplemented
by the sixteenth supplemental indenture, dated as of March 17, 2014, between the Company and the Trustee, as further supplemented by the
seventeenth supplemental indenture, dated as of March 10, 2015, between the Company and the Trustee, as further supplemented by the eighteenth
supplemental indenture, dated as of May 26, 2016, between the Company and the Trustee, as further supplemented by the nineteenth supplemental
indenture, dated as of March 12, 2019, between the Company and the Trustee, as further supplemented by the twentieth supplemental indenture,
dated as of December 16, 2019, between the Company and the Trustee, as further supplemented by the twenty-first supplemental indenture,
dated as of May 13, 2020, between the Company and the Trustee, as further supplemented by the twenty-second supplemental indenture, dated
as of November 1, 2023, between the Company and the Trustee and as further supplemented by the twenty-third supplemental indenture, dated
as of August 19, 2024, between the Company and the Trustee (collectively, as so supplemented, the &#8220;<U>Indenture</U>&#8221;).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">In that connection, we have reviewed originals or copies of the Indenture
(the &#8220;<U>Opinion Document</U>&#8221;).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">We have also reviewed the following:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Registration
Statement;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Prospectus;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">(c) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Copies of the restated
certificate of incorporation and the amended and restated by-laws of the Company, each as amended through the date hereof; and</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 2; Section: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --> -&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Originals or copies
of such other corporate records of the Company, certificates of public officials and of officers of the Company and agreements and other
documents as we have deemed necessary as a basis for the opinions expressed below.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">In our review of the Opinion Document and other documents we have assumed:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The genuineness
of all signatures.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The authenticity
of the originals of the documents submitted to us.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The conformity to
authentic originals of any documents submitted to us as copies.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As to matters of
fact, the truthfulness of the representations made in the Opinion Document and in certificates of public officials and officers of the
Company.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;That the Opinion
Document is the legal, valid and binding obligation of each party thereto, other than the Company, enforceable against each such party
in accordance with its terms.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;That:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 1in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The execution, delivery
and performance by the Company of the Opinion Document does not and will not:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;except with respect
to Generally Applicable Law, violate any law, rule or regulation applicable to it; or</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;result in any conflict
with or breach of any agreement or document binding on it.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 1in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No authorization,
approval, consent or other action by, and no notice to or filing with, any governmental authority or regulatory body or any other third
party is required for the due execution, delivery or performance by the Company of the Opinion Document or, if any such authorization,
approval, consent, action, notice or filing is required, it has been duly obtained, taken, given or made and is in full force and effect.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">We have not independently established the validity of the foregoing assumptions.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&#8220;<U>Generally Applicable Law</U>&#8221; means the federal law of
the United States of America, and the law of the State of New York (including in each case the rules or regulations promulgated thereunder
or pursuant thereto), that a New York lawyer exercising customary professional diligence would reasonably be expected to recognize as
being applicable to the Company, the Opinion Document or the transactions governed by the Opinion Document and for purposes of our assumptions
in paragraph (f) above, the General Corporation Law of the State of Delaware. Without limiting the generality of the foregoing definition
of Generally Applicable Law, the term &#8220;Generally Applicable Law&#8221; does not include any law, rule or regulation that is applicable
to the Company, the Opinion Document or such transactions solely because such law, rule or regulation is part of a regulatory regime applicable
to any party to the Opinion Document or any of its affiliates due to the specific assets or business of such party or such affiliate.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --> -&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">Based upon the foregoing and upon such other investigation as we have deemed
necessary and subject to the qualifications set forth below, we are of the opinion that:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Indenture
constitutes a legal, valid and binding obligation of the Company, enforceable against the Company in accordance with its terms.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;When (i)
the Debt Securities have been duly authorized, (ii) the final terms thereof have been duly established and approved and (iii) the Debt
Securities have been duly executed and delivered by the Company and authenticated by the Trustee in accordance with the Indenture and
delivered to and paid for by the purchasers thereof, the Debt Securities will constitute legal, valid and binding obligations of the Company
enforceable against the Company in accordance with the terms thereof and will be entitled to the benefits of the Indenture.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">Our opinions expressed above are subject to the following qualifications:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our opinions
are subject to the effect of any applicable bankruptcy, insolvency, reorganization, moratorium or similar laws affecting creditors&#8217;
rights generally (including without limitation all laws relating to fraudulent transfers).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our opinions
are also subject to the effect of general principles of equity, including without limitation concepts of materiality, reasonableness,
good faith and fair dealing (regardless of whether considered in a proceeding in equity or at law).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our opinions
are limited to Generally Applicable Law, and we do not express any opinion herein concerning any other law.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">This opinion letter speaks only as of the date hereof. We expressly disclaim
any responsibility to advise you of any development or circumstance of any kind, including any change of law or fact, that may occur after
the date of this opinion letter and which might affect the opinions expressed herein.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">We hereby consent to the filing of this opinion letter as an exhibit to
the Registration Statement and to the use of our name under the heading &#8220;Validity of the Securities&#8221; in the Prospectus. In
giving this consent, we do not hereby admit that we are in the category of persons whose consent is required under Section 7 of the Securities
Act or the rules and regulations of the Securities and Exchange Commission promulgated thereunder.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --> -&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">Very truly yours,</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">/s/ Allen Overy Shearman Sterling US LLP</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">LN/nb/dh</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">EK</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="text-align: center; font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">- 5 -</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>



<P STYLE="margin: 0"></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.2
<SEQUENCE>3
<FILENAME>ss4963221_ex2302.htm
<DESCRIPTION>CONSENT OF PRICEWATERHOUSECOOPERS LLP
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Georgia, Times, Serif; margin: 0; text-align: right"><B>Exhibit 23.2</B></P>

<P STYLE="font: 10pt Georgia, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Georgia, Times, Serif; margin: 24pt 0; text-align: center">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</P>

<P STYLE="font: 10pt Georgia, Times, Serif; margin: 0 0 6pt">We hereby consent to the incorporation by reference in this Registration
Statement on Form&nbsp;S-3 of Quest Diagnostics Incorporated of our report dated February 20, 2025 relating to the financial statements
and the effectiveness of internal control over financial reporting, which appears in Quest Diagnostics Incorporated&rsquo;s Annual Report
on Form 10-K for the year ended December&nbsp;31, 2024. We also consent to the reference to us under the heading &ldquo;Experts&rdquo;
in such Registration Statement.</P>

<P STYLE="font: 10pt Georgia, Times, Serif; margin: 12pt 0 0">/s/ PricewaterhouseCoopers LLP<BR>
Florham Park, New Jersey<BR>
June 20, 2025</P>

<P STYLE="font: 10pt Georgia, Times, Serif; margin: 12pt 0 0">&nbsp;</P>

<P STYLE="font: 10pt Georgia, Times, Serif; margin: 12pt 0 0">&nbsp;</P>

<P STYLE="font: 10pt Georgia, Times, Serif; margin: 12pt 0 0">&nbsp;</P>

<P STYLE="font: 10pt Georgia, Times, Serif; margin: 12pt 0 0">&nbsp;</P>

<P STYLE="font: 10pt Georgia, Times, Serif; margin: 12pt 0 0">&nbsp;</P>

<P STYLE="font: 10pt Georgia, Times, Serif; margin: 12pt 0 0">&nbsp;</P>

<P STYLE="font: 10pt Georgia, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Georgia, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Georgia, Times, Serif; margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-25.1
<SEQUENCE>4
<FILENAME>ss4963221_ex2501.htm
<DESCRIPTION>FORM T-1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>



<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"><B>Exhibit 25.1</B></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 12pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">UNITED STATES</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">SECURITIES AND EXCHANGE COMMISSION</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 12pt">Washington, D.C. 20549</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 12pt">FORM T-1</p>

<p style="font: 12pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 12pt">STATEMENT OF ELIGIBILITY<BR>
UNDER THE TRUST INDENTURE ACT OF 1939 OF A<BR>
CORPORATION DESIGNATED TO ACT AS TRUSTEE</p>

<p style="font: 12pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">CHECK IF AN APPLICATION TO DETERMINE<BR>
ELIGIBILITY OF A TRUSTEE PURSUANT TO<BR>
SECTION 305(b)(2)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;|__|</p>

<p style="font: 12pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 12pt"><font style="text-decoration: underline solid">___________________________</font></p>

<p style="font: 12pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 12pt">THE BANK OF NEW YORK MELLON<BR>(Exact name of trustee as specified in its charter)</p>

<table cellpadding="0" cellspacing="0" width="100%" style="border-collapse: collapse; border: solid 0.5pt black; font-size: 11pt">
  <tr>
    <td style="width: 68%; vertical-align: top"><P STYLE="font: 12pt Times New Roman, Times, Serif; padding-left: 6pt; text-align: left; margin-top: 0pt; margin-bottom: 12pt">New York<BR>(Jurisdiction of incorporation<BR>if not a U.S. national bank)</p></td>
    <td style="width: 32%; border-left: solid 0.5pt black; vertical-align: top"><P STYLE="font: 12pt Times New Roman, Times, Serif; padding-left: 6pt; text-align: left; margin-top: 0pt; margin-bottom: 12pt">13-5160382<BR>(I.R.S. employer<BR>identification no.)</p></td></tr>
  <tr>
    <td style="border-top: solid 0.5pt black; vertical-align: top"><P STYLE="font: 12pt Times New Roman, Times, Serif; padding-left: 6pt; text-align: left; margin-top: 0pt; margin-bottom: 12pt">240 Greenwich Street, New York, N.Y.<BR>(Address of principal executive offices)</p></td>
    <td style="border-left: solid 0.5pt black; border-top: solid 0.5pt black; vertical-align: top"><P STYLE="font: 12pt Times New Roman, Times, Serif; padding-left: 6pt; text-align: left; margin-top: 0pt; margin-bottom: 12pt">10286<BR>(Zip code)</p></td></tr>
  </table>

<p style="font: 12pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 12pt"><font style="text-decoration: underline solid"><BR>___________________________</font></p>

<p style="font: 12pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 6pt">QUEST DIAGNOSTICS INCORPORATED<BR>(Exact name of obligor as specified in its charter)</p>

<table cellpadding="0" cellspacing="0" width="100%" style="border-collapse: collapse; border: solid 0.5pt black; font-size: 11pt">
  <tr>
    <td style="width: 68%; vertical-align: top"><P STYLE="font: 12pt Times New Roman, Times, Serif; padding-left: 6pt; text-align: left; margin-top: 0pt; margin-bottom: 6pt">Delaware<BR>(State or other jurisdiction of<BR>incorporation or organization)</p></td>
    <td style="width: 32%; border-left: solid 0.5pt black; vertical-align: top"><P STYLE="padding-left: 6pt; font: 12pt Times New Roman, Times, Serif; text-align: left; margin-top: 2.65pt; margin-bottom: 6pt">16-1387862<BR>(I.R.S. employer<BR>identification no.)</p></td></tr>
  <tr>
    <td style="border-top: solid 0.5pt black; vertical-align: top"><P STYLE="padding-left: 6pt; font: 12pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">500 Plaza Drive<BR>Secaucus, New Jersey<BR>(Address of principal executive offices)</p></td>
    <td style="border-left: solid 0.5pt black; border-top: solid 0.5pt black; vertical-align: top"><P STYLE="padding-left: 6pt; font: 12pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 12pt"><BR>07094<BR>(Zip code)</p></td></tr>
  </table>

<p style="font: 12pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 12pt"><font style="text-decoration: underline solid">___________________________</font></p>

<p style="font: 12pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><font style="color: Black">Debt Securities</font> <BR>(Title of the indenture securities)</p>

<p style="font: 12pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 12pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 12pt"><BR></p>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 12pt"><tr style="vertical-align: top">
<TD STYLE="width: 0.5in"><B>1.</B></td><TD STYLE="text-align: justify"><b>General information. Furnish the following information as to the Trustee:</b></td></tr></table>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 12pt"><tr style="vertical-align: top">
<TD STYLE="width: 0.5in">&nbsp;</td><TD STYLE="width: 0.25in"><b>(a)</b></td><TD STYLE="text-align: justify"><b>Name and address of each examining or supervising authority to which it is subject.</b></td></tr></table>

<table cellpadding="0" cellspacing="0" width="100%" style="border-collapse: collapse; font-size: 11pt">
  <tr>
    <td style="width: 59%; vertical-align: middle; border-top: dashed 0.5pt black; border-bottom: dashed 0.5pt black"><p style="font: 12pt Times New Roman, Times, Serif; text-align: center; margin-top: 6pt; margin-bottom: 6pt; margin-right: 48.6pt">Name</p></td>
    <td style="width: 41%; vertical-align: middle; border-top: dashed 0.5pt black; border-bottom: dashed 0.5pt black"><p style="font: 12pt Times New Roman, Times, Serif; text-align: center; margin-top: 6pt; margin-bottom: 6pt">Address</p></td></tr>
  <tr>
    <td style="vertical-align: top"><p style="font: 12pt Times New Roman, Times, Serif; margin: 12pt 21.6pt 12pt 31.5pt; text-align: left">Superintendent of the Department of Financial Services of the State of New York</p></td>
    <td style="vertical-align: top"><p style="font: 12pt Times New Roman, Times, Serif; text-align: left; margin-top: 12pt; margin-bottom: 12pt">One State Street, New York, N.Y. 10004-1417, and Albany, N.Y. 12223</p></td></tr>
  <tr>
    <td style="vertical-align: top"><p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt 21.6pt 12pt 31.5pt; text-align: left">Federal Reserve Bank of New York</p></td>
    <td style="vertical-align: top"><p style="font: 12pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 12pt">33 Liberty Street, New York, N.Y. 10045</p></td></tr>
  <tr>
    <td style="vertical-align: top"><p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt 21.6pt 12pt 31.5pt; text-align: left">Federal Deposit Insurance Corporation</p></td>
    <td style="vertical-align: top"><p style="font: 12pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 12pt">550 17<sup>th</sup> Street, NW<BR>Washington, D.C. 20429</p></td></tr>
  <tr>
    <td style="vertical-align: top"><p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt 21.6pt 12pt 31.5pt; text-align: left">The Clearing House Association L.L.C.</p></td>
    <td style="vertical-align: top"><p style="font: 12pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 12pt">100 Broad Street<BR>New York, N.Y. 10004</p></td></tr>
  </table>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 12pt"><tr style="vertical-align: top">
<TD STYLE="width: 0.5in">&nbsp;</td><TD STYLE="width: 0.25in"><b>(b)</b></td><TD STYLE="text-align: justify"><b>Whether it is authorized to exercise corporate trust powers.</b></td></tr></table>

<p style="font: 12pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 12pt; margin-left: 36pt">Yes.</p>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 12pt"><tr style="vertical-align: top">
<TD STYLE="width: 0.5in"><b>2.</b></td><TD STYLE="text-align: justify"><b>Affiliations with Obligor.</b></td></tr></table>

<p style="font: 12pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 12pt; margin-left: 36pt"><b>If the obligor is an affiliate of the trustee, describe each such affiliation. </b></p>

<p style="font: 12pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 12pt; margin-left: 36pt">None.</p>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 12pt"><tr style="vertical-align: top">
<TD STYLE="width: 0.5in"><b>16.</b></td><TD STYLE="text-align: justify"><b>List of Exhibits. </b></td></tr></table>

<p style="font: 12pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 12pt; margin-left: 36pt"><b>Exhibits identified in parentheses below, on file with the Commission, are incorporated herein by reference as an exhibit hereto,
pursuant to Rule 7a-29 under the Trust Indenture Act of 1939 (the &ldquo;Act&rdquo;).</b></p>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 12pt"><tr style="vertical-align: top">
<TD STYLE="width: 0.5in">&nbsp;</td><TD STYLE="width: 0.25in">1.</td><TD STYLE="text-align: left">A copy of the Organization Certificate of The Bank of New York Mellon (formerly known as The Bank of New York, itself formerly Irving
Trust Company) as now in effect, which contains the authority to commence business and a grant of powers to exercise corporate trust
powers. (Exhibit 1 to Amendment No.&#160;1 to Form T-1 filed with Registration Statement No. 33-6215, Exhibits 1a and 1b to Form T-1
filed with Registration Statement No. 33-21672, Exhibit 1 to Form T-1 filed with Registration Statement No. 33-29637, Exhibit 1 to Form
T-1 filed with Registration Statement No. 333-121195 and Exhibit 1 to Form T-1 filed with Registration Statement No. 333-152735).</td></tr></table>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 12pt"><tr style="vertical-align: top">
<TD STYLE="width: 0.5in">&nbsp;</td><TD STYLE="width: 0.25in">4.</td><TD STYLE="text-align: justify">A copy of the existing By-laws of the Trustee (Exhibit 4 to Form T-1 filed with Registration Statement No. 333-261533).</td></tr></table>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 12pt"><tr style="vertical-align: top">
<TD STYLE="width: 0.5in">&nbsp;</td><TD STYLE="width: 0.25in">6.</td><TD STYLE="text-align: justify">The consent of the Trustee required by Section 321(b) of the Act (Exhibit 6 to Form T-1 filed with Registration Statement No. 333-229519).</td></tr></table>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 12pt"><tr style="vertical-align: top">
<TD STYLE="width: 0.5in">&nbsp;</td><TD STYLE="width: 0.25in">7.</td><TD STYLE="text-align: justify">A copy of the latest report of condition of the Trustee published pursuant to law or to the requirements of its supervising or examining
authority.</td></tr></table>

<p style="font: 12pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 24pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 24pt"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 24pt"><BR>SIGNATURE</p>

<p style="font: 12pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 12pt; text-indent: 36pt">Pursuant
to the requirements of the Act, the trustee, The Bank of New York Mellon, a corporation organized and existing under the laws of the
State of New York, has duly caused this statement of eligibility to be signed on its behalf by the undersigned, thereunto duly authorized,
all in the City of New York, and State of New York, on the <BR>17th day of June, 2025.</P>

<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="2"><B>THE BANK OF NEW YORK MELLON</B></TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; width: 50%">&nbsp;</TD>
    <TD STYLE="width: 4%">By:&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 46%">/s/ Glenn J. Kunak</TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-top: #000000 1px solid; vertical-align: top">Name: Glenn J. Kunak<BR>Title: &nbsp;Vice President</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0pt; margin-top: 0pt; margin-bottom: 6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0pt; margin-top: 0pt; margin-bottom: 6pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 18pt; margin-left: 216pt"></p>




<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B><U>EXHIBIT 7</U></B></P>

<P STYLE="margin: 0">&nbsp;</P>

<DIV STYLE="padding: 0in; border-top: Black 0.5pt solid">
&nbsp;

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%">
  <TR>
    <TD>
&nbsp;</TD></TR>
  </TABLE>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">Consolidated&nbsp;Report&nbsp;of&nbsp;Condition&nbsp;of</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

</DIV>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center">THE BANK OF NEW YORK MELLON</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">of 240 Greenwich Street, New York, N.Y. 10286<BR>
And Foreign and Domestic Subsidiaries,</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">a member of the Federal Reserve System, at
the close of business March 31, 2025, published in accordance with a call made by the Federal Reserve Bank of this District pursuant to
the provisions of the Federal Reserve Act.</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 12pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left"><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 26.1pt 0 0; text-align: left"><B>ASSETS</B></P> <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 26.1pt 0 0; text-align: left"><B>&nbsp;</B></P></TD><TD>&nbsp;</TD>
    <TD COLSPAN="3">Dollar amounts in thousands</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 9pt">Cash and balances due from depository institutions:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 70%; text-align: left; text-indent: -9pt; padding-left: 0.25in">Noninterest-bearing balances and currency and coin&#9;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 26%; text-align: right">3,927,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 0.25in">Interest-bearing balances&#9;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">110,444,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 9pt">Securities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 0.25in">Held-to-maturity securities&#9;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">48,493,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 0.25in">Available-for-sale debt securities&#9;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">96,644,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 0.25in">Equity securities with readily determinable fair values not held for trading</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 9pt">Federal funds sold and securities purchased under agreements to resell:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 9pt">&nbsp;&nbsp;&nbsp;Federal funds sold in domestic offices&#9;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 9pt">&nbsp;&nbsp;&nbsp;Securities purchased under agreements to resell</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">23,768,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 9pt">Loans and lease financing receivables:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 0.25in">Loans and leases held for sale</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 0.25in">Loans and leases held for investment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">35,999,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 0.25in">LESS: Allowance for credit losses on <BR> loans and leases&#9;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">272,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 0.25in">Loans and leases held for investment, net of allowance&#9;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">35,727,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 9pt">Trading assets&#9;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,238,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 9pt">Premises and fixed assets (including right-of-use assets)&#9;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,907,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 9pt">Other real estate owned&#9;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 9pt">Investments in unconsolidated subsidiaries and associated companies&#9;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,986,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Direct and indirect investments in real estate ventures</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 9pt">Intangible assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7,338,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -9pt; padding-left: 9pt">Other assets&#9;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">18,790,000</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt">Total assets&#9;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">356,262,000</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 12pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; text-indent: -9pt; padding-left: 9pt; width: 70%">LIABILITIES<BR> <BR></TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 1%">&nbsp;</TD><TD STYLE="text-align: right; width: 26%">&nbsp;</TD><TD STYLE="text-align: left; width: 1%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 9pt">Deposits:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 0.25in">In domestic offices&#9;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">202,806,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 0.25in">Noninterest-bearing&#9;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">54,490,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 0.25in">Interest-bearing&#9;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">148,316,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 0.25in">In foreign offices, Edge and Agreement subsidiaries, and IBFs&#9;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">107,974,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 0.25in">Noninterest-bearing&#9;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,891,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 0.25in">Interest-bearing&#9;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">104,083,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -0.25in; padding-left: 0.25in">Federal funds purchased and securities sold under agreements to repurchase:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 9pt">&nbsp;&nbsp;&nbsp;Federal funds purchased in domestic offices</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 9pt">Securities sold under agreements to repurchase&#9;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,958,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 9pt">Trading liabilities&#9;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,927,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 9pt">Other borrowed money:<BR> (includes mortgage indebtedness)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,881,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 9pt">Not applicable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 9pt">Not applicable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 9pt">Subordinated notes and debentures&#9;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -9pt; padding-left: 9pt">Other liabilities&#9;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">7,044,000</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt">Total liabilities&#9;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">326,590,000</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: left; text-indent: -9pt; padding-left: 9pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; text-indent: -9pt; padding-left: 9pt">EQUITY CAPITAL</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 9pt">Perpetual preferred stock and related <BR> surplus</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 9pt">Common stock&#9;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,135,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 9pt">Surplus (exclude all surplus related to preferred stock)&#9;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">12,669,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 9pt">Retained earnings&#9;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">18,503,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 9pt">Accumulated other comprehensive income</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-2,635,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 9pt">Other equity capital components</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 9pt">Total bank equity capital&#9;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">29,672,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 9pt">Noncontrolling (minority) interests in <BR> consolidated subsidiaries</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -9pt; padding-left: 9pt">Total equity capital&#9;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">29,672,000</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt">Total liabilities and equity capital&#9;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">356,262,000</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 24pt 0 12pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 24pt 0 12pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 24pt 0 12pt; text-align: justify; text-indent: 0.5in">I, Dermot McDonogh,
Chief Financial Officer of the above-named bank do hereby declare that this Report of Condition is true and correct to the best of my
knowledge and belief.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0.5in 12pt 0; text-align: right; text-indent: 1in">Dermot McDonogh<BR>
Chief Financial Officer</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">We, the undersigned directors,
attest to the correctness of this statement of resources and liabilities. We declare that it has been examined by us, and to the best
of our knowledge and belief has been prepared in conformance with the instructions and is true and correct.</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 39%; padding-top: 0px; padding-right: 1.8pt; padding-left: 10pt; text-align: left">Robin A. Vince <BR>
Jeffrey A. Goldstein<BR>
Joseph J. Echevarria</TD>
    <TD STYLE="width: 9%">&nbsp;<IMG SRC="image_002.jpg" ALT=""></TD>
    <TD STYLE="width: 52%; padding-top: 3pt; padding-bottom: 3pt; text-align: left">Directors</TD></TR>
  </TABLE>


<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">&nbsp;</P>



<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>5
<FILENAME>ss4963221_ex107.htm
<DESCRIPTION>FILING FEE IXBRL
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ffd="http://xbrl.sec.gov/ffd/2025" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:DGX="http://DGX/20250620">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_027_FFD%2D2025 -->
<!-- Field: Set; Name: xdx; ID: xdx_03F_DGX_DGX_20250620 -->
<!-- Field: Set; Name: xdx; ID: xdx_044_20250620_20250620 -->
<!-- Field: Set; Name: xdx; ID: xdx_054_edei%2D%2DEntityCentralIndexKey_0001022079 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_065_Ratio_4_xbrli%2D%2Dpure -->
<body>
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2025-06-20" id="Fact000003" name="dei:EntityCentralIndexKey">0001022079</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2025-06-20">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-06-20</xbrli:startDate>
        <xbrli:endDate>2025-06-20</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-06-202025-06-20_1">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:typedMember dimension="ffd:OfferingAxis">
            <dei:lineNo>1</dei:lineNo>
          </xbrldi:typedMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-06-20</xbrli:startDate>
        <xbrli:endDate>2025-06-20</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Ratio">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; display: none; text-align: right"><b><span id="xdx_901_effd--SubmissnTp_c20250620__20250620_zrAZkgUChYCa"><ix:nonNumeric contextRef="AsOf2025-06-20" id="Fact000009" name="ffd:SubmissnTp">S-3ASR</ix:nonNumeric></span>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; display: none; text-align: right"><span id="xdx_904_effd--FeeExhibitTp_c20250620__20250620_zAXD25vVZ1Kh"><ix:nonNumeric contextRef="AsOf2025-06-20" id="Fact000010" name="ffd:FeeExhibitTp">EX-FILING FEES</ix:nonNumeric></span><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>Exhibit 107</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Calculation of Filing Fee Tables</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Form <span id="xdx_909_effd--FormTp_c20250620__20250620_zZNTPwMVbX"><ix:nonNumeric contextRef="AsOf2025-06-20" id="Fact000011" name="ffd:FormTp">S-3</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Form Type)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b><span id="xdx_90D_edei--EntityRegistrantName_c20250620__20250620_zqplwgZvncVc"><ix:nonNumeric contextRef="AsOf2025-06-20" id="Fact000012" name="dei:EntityRegistrantName">Quest Diagnostics Incorporated</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Exact Name of Registrant as Specified in its Charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="text-decoration: underline">Table 1: Newly Registered and Carry Forward Securities</span></p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.25pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-size: 7pt"><b>Security<br/>
Type</b></span></td>
    <td style="padding-bottom: 1.25pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 7pt"><b>Security<br/>
Class Title</b></span></td>
    <td style="padding-bottom: 1.25pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-size: 7pt"><b>Fee<br/>
Calculation<br/>
or Carry<br/>
Forward<br/>
Rule</b></span></td>
    <td style="padding-bottom: 1.25pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 7pt"><b>Amount<br/>
Registered</b></span></td>
    <td style="padding-bottom: 1.25pt">&#160;</td>
    <td style="padding-bottom: 1.25pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-size: 7pt"><b>Proposed<br/>
Maximum<br/>
Offering<br/>
Price Per<br/>
Unit</b></span></td>
    <td style="padding-bottom: 1.25pt">&#160;</td>
    <td style="padding-bottom: 1.25pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-size: 7pt"><b>Maximum <br/>
Aggregate <br/>
Offering <br/>
Price</b></span></td>
    <td style="padding-bottom: 1.25pt">&#160;</td>
    <td style="padding-bottom: 1.25pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 7pt"><b>Fee <br/>
Rate</b></span></td>
    <td style="padding-bottom: 1.25pt">&#160;</td>
    <td style="padding-bottom: 1.25pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-size: 7pt"><b>Amount of <br/>
Registration <br/>
Fee</b></span></td>
    <td style="padding-bottom: 1.25pt">&#160;</td>
    <td style="padding-bottom: 1.25pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 7pt"><b>Carry <br/>
Forward <br/>
Form <br/>
Type</b></span></td>
    <td style="padding-bottom: 1.25pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 7pt"><b>Carry <br/>
Forward <br/>
File <br/>
Number</b></span></td>
    <td style="padding-bottom: 1.25pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 7pt"><b>Carry <br/>
Forward <br/>
Initial <br/>
Effective <br/>
Date</b></span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-size: 7pt"><b>Filing Fee<br/>
Previously<br/>
Paid in<br/>
Connection<br/>
with <br/>
Unsold<br/>
Securities<br/>
to be<br/>
Carried<br/>
Forward</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td colspan="33" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 7pt">Newly Registered Securities</span></td>
    <td style="border-bottom: black 1pt solid; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: white">
    <td id="xdx_981_effd--PrevslyPdFlg_dbF_c20250620__20250620__ffd--OfferingAxis__1_zyYmwpDbRI8b" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt; padding-left: 5.65pt; text-align: center"><span style="font-size: 7pt"><ix:nonNumeric contextRef="From2025-06-202025-06-20_1" format="ixt:booleanfalse" id="Fact000013" name="ffd:PrevslyPdFlg">Fees to Be Paid</ix:nonNumeric></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt; text-align: center"><span style="font-size: 7pt">1</span></td>
    <td id="xdx_985_effd--OfferingSctyTp_c20250620__20250620__ffd--OfferingAxis__1_zMXSVv6mlDri" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt; padding-left: 5.65pt; text-align: center"><span style="font-size: 7pt"><ix:nonNumeric contextRef="From2025-06-202025-06-20_1" id="Fact000014" name="ffd:OfferingSctyTp">Debt</ix:nonNumeric></span></td>
    <td style="padding-bottom: 1.25pt">&#160;</td>
    <td id="xdx_98E_effd--OfferingSctyTitl_c20250620__20250620__ffd--OfferingAxis__1_z78qWBS80JFh" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt; padding-left: 5.65pt; text-align: center"><span style="font-size: 7pt"><ix:nonNumeric contextRef="From2025-06-202025-06-20_1" id="Fact000015" name="ffd:OfferingSctyTitl">Debt Securities</ix:nonNumeric></span></td>
    <td style="padding-bottom: 1.25pt">&#160;</td>
    <td id="xdx_989_effd--Rule457rFlg_dbT_c20250620__20250620__ffd--OfferingAxis__1_zfKQD7HUfqgj" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt; padding-left: 5.65pt; text-align: center"><span style="font-size: 7pt"><ix:nonNumeric contextRef="From2025-06-202025-06-20_1" format="ixt:booleantrue" id="Fact000016" name="ffd:Rule457rFlg">Rule 456(b) and Rule 457(r)</ix:nonNumeric></span></td>
    <td style="padding-bottom: 1.25pt">&#160;</td>
    <td colspan="3">&#160;</td>
    <td style="padding-bottom: 1.25pt">&#160;</td>
    <td colspan="3">&#160;</td>
    <td style="padding-bottom: 1.25pt">&#160;</td>
    <td colspan="3">&#160;</td>
    <td style="padding-bottom: 1.25pt">&#160;</td>
    <td colspan="3" id="xdx_98B_effd--FeeRate_dp_c20250620__20250620__ffd--OfferingAxis__1_zMEyy81a3uqc"><span style="font-size: 7pt"><ix:nonFraction name="ffd:FeeRate" contextRef="From2025-06-202025-06-20_1" id="Fact000017" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">0.0001531</ix:nonFraction></span></td>
    <td style="padding-bottom: 1.25pt">&#160;</td>
    <td colspan="3">&#160;</td>
    <td style="padding-bottom: 1.25pt">&#160;</td>
    <td style="padding-bottom: 1.25pt; padding-left: 5.65pt">&#160;</td>
    <td style="padding-bottom: 1.25pt">&#160;</td>
    <td style="padding-bottom: 1.25pt; padding-left: 5.65pt">&#160;</td>
    <td style="padding-bottom: 1.25pt">&#160;</td>
    <td style="padding-bottom: 1.25pt; padding-left: 5.65pt">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt; padding-left: 5.65pt; text-align: center"><span style="font-size: 7pt">Fees Previously Paid</span></td>
    <td style="padding-bottom: 1.25pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt; padding-left: 5.65pt; text-align: center">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt; padding-left: 5.65pt; text-align: center">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt; padding-left: 5.65pt; text-align: center">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt; text-align: center">&#160;</td>
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt; text-align: center">&#160;</td>
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt; text-align: center">&#160;</td>
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt; text-align: center">&#160;</td>
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt; text-align: center">&#160;</td>
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="padding-bottom: 1.25pt">&#160;</td>
    <td style="padding-bottom: 1.25pt; padding-left: 5.65pt">&#160;</td>
    <td style="padding-bottom: 1.25pt">&#160;</td>
    <td style="padding-bottom: 1.25pt; padding-left: 5.65pt">&#160;</td>
    <td style="padding-bottom: 1.25pt">&#160;</td>
    <td style="padding-bottom: 1.25pt; padding-left: 5.65pt">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td colspan="33" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 7pt">Carry Forward Securities</span></td>
    <td style="border-bottom: black 1pt solid; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 9%; padding-bottom: 1.25pt; padding-left: 5.65pt; text-align: center"><span style="font-size: 7pt">Carry Forward Securities</span></td>
    <td style="width: 4%; padding-bottom: 1.25pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%; padding-bottom: 1.25pt; padding-left: 5.65pt; text-align: center">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.25pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 9%; padding-bottom: 1.25pt; padding-left: 5.65pt; text-align: center">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.25pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 6%; padding-bottom: 1.25pt; padding-left: 5.65pt; text-align: center">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.25pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.25pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.25pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.25pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.25pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.25pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.25pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 3%; text-align: right">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.25pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.25pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.25pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.25pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%; padding-bottom: 1.25pt; padding-left: 5.65pt; text-align: center">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.25pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%; padding-bottom: 1.25pt; padding-left: 5.65pt; text-align: center">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.25pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%; padding-bottom: 1.25pt; padding-left: 5.65pt; text-align: center">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: white">
    <td style="padding-bottom: 1.25pt; padding-left: 5.65pt">&#160;</td>
    <td style="padding-bottom: 1.25pt">&#160;</td>
    <td style="padding-bottom: 1.25pt; padding-left: 5.65pt">&#160;</td>
    <td style="padding-bottom: 1.25pt">&#160;</td>
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt; padding-left: 5.65pt; text-align: center"><span style="font-size: 7pt">Total Offering Amounts</span></td>
    <td style="padding-bottom: 1.25pt">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="padding-bottom: 1.25pt">&#160;</td>
    <td style="padding-bottom: 1.25pt">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="padding-bottom: 1.25pt">&#160;</td>
    <td style="padding-bottom: 1.25pt">&#160;</td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 7pt">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span id="xdx_900_effd--TtlOfferingAmt_c20250620__20250620_z5kZMp952Ia6"><ix:nonFraction name="ffd:TtlOfferingAmt" contextRef="AsOf2025-06-20" id="Fact000018" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0.00</ix:nonFraction></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 7pt">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span id="xdx_900_effd--TtlFeeAmt_c20250620__20250620_z86K4cB1hup8"><ix:nonFraction name="ffd:TtlFeeAmt" contextRef="AsOf2025-06-20" id="Fact000019" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0.00</ix:nonFraction></span></span></td>
    <td style="padding-bottom: 1.25pt">&#160;</td>
    <td style="padding-bottom: 1.25pt">&#160;</td>
    <td style="padding-bottom: 1.25pt; padding-left: 5.65pt">&#160;</td>
    <td style="padding-bottom: 1.25pt">&#160;</td>
    <td style="padding-bottom: 1.25pt; padding-left: 5.65pt">&#160;</td>
    <td style="padding-bottom: 1.25pt">&#160;</td>
    <td style="padding-bottom: 1.25pt; padding-left: 5.65pt">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="padding-bottom: 1.25pt; padding-left: 5.65pt">&#160;</td>
    <td style="padding-bottom: 1.25pt">&#160;</td>
    <td style="padding-bottom: 1.25pt; padding-left: 5.65pt">&#160;</td>
    <td style="padding-bottom: 1.25pt">&#160;</td>
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt; padding-left: 5.65pt; text-align: center"><span style="font-size: 7pt">Total Fees Previously Paid</span></td>
    <td style="padding-bottom: 1.25pt">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="padding-bottom: 1.25pt">&#160;</td>
    <td style="padding-bottom: 1.25pt">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="padding-bottom: 1.25pt">&#160;</td>
    <td style="padding-bottom: 1.25pt">&#160;</td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 7pt">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span id="xdx_903_effd--TtlPrevslyPdAmt_c20250620__20250620_zIlHWMRGlqe9"><ix:nonFraction name="ffd:TtlPrevslyPdAmt" contextRef="AsOf2025-06-20" id="Fact000020" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0.00</ix:nonFraction></span></span></td>
    <td style="padding-bottom: 1.25pt">&#160;</td>
    <td style="padding-bottom: 1.25pt">&#160;</td>
    <td style="padding-bottom: 1.25pt; padding-left: 5.65pt">&#160;</td>
    <td style="padding-bottom: 1.25pt">&#160;</td>
    <td style="padding-bottom: 1.25pt; padding-left: 5.65pt">&#160;</td>
    <td style="padding-bottom: 1.25pt">&#160;</td>
    <td style="padding-bottom: 1.25pt; padding-left: 5.65pt">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top; background-color: white">
    <td style="padding-bottom: 1.25pt; padding-left: 5.65pt">&#160;</td>
    <td style="padding-bottom: 1.25pt">&#160;</td>
    <td style="padding-bottom: 1.25pt; padding-left: 5.65pt">&#160;</td>
    <td style="padding-bottom: 1.25pt">&#160;</td>
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt; padding-left: 5.65pt; text-align: center"><span style="font-size: 7pt">Total Fee Offsets</span></td>
    <td style="padding-bottom: 1.25pt">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="padding-bottom: 1.25pt">&#160;</td>
    <td style="padding-bottom: 1.25pt">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="padding-bottom: 1.25pt">&#160;</td>
    <td style="padding-bottom: 1.25pt">&#160;</td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 7pt">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span id="xdx_90B_effd--TtlOffsetAmt_c20250620__20250620_zqo6PqJgLgBl"><ix:nonFraction name="ffd:TtlOffsetAmt" contextRef="AsOf2025-06-20" id="Fact000021" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0.00</ix:nonFraction></span></span></td>
    <td style="padding-bottom: 1.25pt">&#160;</td>
    <td style="padding-bottom: 1.25pt">&#160;</td>
    <td style="padding-bottom: 1.25pt; padding-left: 5.65pt">&#160;</td>
    <td style="padding-bottom: 1.25pt">&#160;</td>
    <td style="padding-bottom: 1.25pt; padding-left: 5.65pt">&#160;</td>
    <td style="padding-bottom: 1.25pt">&#160;</td>
    <td style="padding-bottom: 1.25pt; padding-left: 5.65pt">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="padding-bottom: 1.25pt; padding-left: 5.65pt">&#160;</td>
    <td style="padding-bottom: 1.25pt">&#160;</td>
    <td style="padding-bottom: 1.25pt; padding-left: 5.65pt">&#160;</td>
    <td style="padding-bottom: 1.25pt">&#160;</td>
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt; padding-left: 5.65pt; text-align: center"><span style="font-size: 7pt">Net Fee Due</span></td>
    <td style="padding-bottom: 1.25pt">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="padding-bottom: 1.25pt">&#160;</td>
    <td style="padding-bottom: 1.25pt">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="padding-bottom: 1.25pt">&#160;</td>
    <td style="padding-bottom: 1.25pt">&#160;</td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 7pt">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span id="xdx_907_effd--NetFeeAmt_c20250620__20250620_zjyAzRqdr4R4"><ix:nonFraction name="ffd:NetFeeAmt" contextRef="AsOf2025-06-20" id="Fact000022" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0.00</ix:nonFraction></span></span></td>
    <td style="padding-bottom: 1.25pt">&#160;</td>
    <td style="padding-bottom: 1.25pt">&#160;</td>
    <td style="padding-bottom: 1.25pt; padding-left: 5.65pt">&#160;</td>
    <td style="padding-bottom: 1.25pt">&#160;</td>
    <td style="padding-bottom: 1.25pt; padding-left: 5.65pt">&#160;</td>
    <td style="padding-bottom: 1.25pt">&#160;</td>
    <td style="padding-bottom: 1.25pt; padding-left: 5.65pt">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.3pt"/><td style="width: 18pt">(1)</td><td id="xdx_982_effd--OfferingNote_c20250620__20250620__ffd--OfferingAxis__1_zE50WhP41Vzf"><ix:nonNumeric contextRef="From2025-06-202025-06-20_1" escape="true" id="Fact000023" name="ffd:OfferingNote">The registrant is relying on Rule 456(b) and Rule 457(r) under the Securities Act of 1933, as amended, to defer payment of all of
the registration fee. In connection with the securities offered hereby, the registrant will pay &#8220;pay-as-you-go registration fees&#8221;
in accordance with Rule 456(b). The registrant will calculate the registration fee applicable to an offer of securities pursuant to this
registration statement based on the fee payment rate in effect on the date of such fee payment. An unspecified aggregate initial offering
price and number of securities of the identified class is being registered and may from time to time be offered at unspecified prices.</ix:nonNumeric></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>


<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjd0KwjAMhZ9g7xB6LboOf3CXDhVxyhgi3hYXpbg1I63TPZJvabchhkBIzvlyhBiJLW10iQyXVZ7CCau6VA4hxxsymit6R7Lbx+BnjndtHSvj+vUHJuQZ9Mx8LJW/985GWyxiCOcTuZxEMwinsVxAdhBBpydkbrpA47QqQZkCMqaaNTrF7fDhpN5kqGr7pDOy1WRikONwkD8QhTKCIzXqRfywkKaJCEZ9BWLL9Ky9a/12aDoS1iVWPs4O9L+DL8+JSmM= -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  4 -H# 2(  A$! Q$!_\0
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M%C 8D@'K/VNH?A!X@\&Z/X5^+FJ+H]KK5^L>E7BEDE@NE&/-60*5C #X+/\
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::.SM8-S-Y<4:A$7+$DX4 9))K0HHH+V/_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !$ !0# 2(  A$! Q$!_\0
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)<]_2BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Submission<br></strong></div></th>
<th class="th"><div>Jun. 20, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissionLineItems', window );"><strong>Submission [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Central Index Key</a></td>
<td class="text">0001022079<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Registrant Name</a></td>
<td class="text">Quest Diagnostics Incorporated<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FormTp', window );">Form Type</a></td>
<td class="text">S-3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissnTp', window );">Submission Type</a></td>
<td class="text">S-3ASR<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeExhibitTp', window );">Fee Exhibit Type</a></td>
<td class="text">EX-FILING FEES<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeExhibitTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeExhibitTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:feeExhibitTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FormTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FormTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissnTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissnTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Offerings - Offering: 1<br></strong></div></th>
<th class="th"><div>Jun. 20, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457rFlg', window );">Rule 457(r)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Debt<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Debt Securities<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.00015%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">The registrant is relying on Rule 456(b) and Rule 457(r) under the Securities Act of 1933, as amended, to defer payment of all of
the registration fee. In connection with the securities offered hereby, the registrant will pay &#8220;pay-as-you-go registration fees&#8221;
in accordance with Rule 456(b). The registrant will calculate the registration fee applicable to an offer of securities pursuant to this
registration statement based on the fee payment rate in effect on the date of such fee payment. An unspecified aggregate initial offering
price and number of securities of the identified class is being registered and may from time to time be offered at unspecified prices.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTitl">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The title of the class of securities being registered (for each class being registered).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTitl</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Type of securities: "Asset-backed Securities", "ADRs/ADSs", "Debt", "Debt Convertible into Equity", "Equity", "Face Amount Certificates", "Limited Partnership Interests", "Mortgage Backed Securities", "Non-Convertible Debt", "Unallocated (Universal) Shelf", "Exchange Traded Vehicle Securities", "Other"</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_PrevslyPdFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_PrevslyPdFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_Rule457rFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 457<br> -Subsection r<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_Rule457rFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fees Summary<br></strong></div></th>
<th class="th">
<div>Jun. 20, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesSummaryLineItems', window );"><strong>Fees Summary [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOfferingAmt', window );">Total Offering</a></td>
<td class="nump">$ 0.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlPrevslyPdAmt', window );">Previously Paid Amount</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlFeeAmt', window );">Total Fee Amount</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOffsetAmt', window );">Total Offset Amount</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NetFeeAmt', window );">Net Fee</a></td>
<td class="nump">$ 0.00<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesSummaryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesSummaryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NetFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NetFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOfferingAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOfferingAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOffsetAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOffsetAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlPrevslyPdAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlPrevslyPdAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>2</ContextCount>
  <ElementCount>16</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>1</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="ss4963221_ex107.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995210 - Document - Submission</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/submissionTable</Role>
      <ShortName>Submission</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="ss4963221_ex107.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995211 - Document - Offerings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesOfferingTable</Role>
      <ShortName>Offerings</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="ss4963221_ex107.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>995215 - Document - Fees Summary</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesSummaryTable</Role>
      <ShortName>Fees Summary</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="EX-FILING FEES" original="ss4963221_ex107.htm">ss4963221_ex107.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="2">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
    <BaseTaxonomy items="14">http://xbrl.sec.gov/ffd/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>18
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ss4963221_ex107.htm": {
   "dts": {
    "inline": {
     "local": [
      "ss4963221_ex107.htm"
     ]
    },
    "schema": {
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/arcrole/deprecated-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd"
     ]
    }
   },
   "keyStandard": 16,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 0,
   "hidden": {
    "total": 1,
    "http://xbrl.sec.gov/dei/2025": 1
   },
   "contextCount": 2,
   "entityCount": 1,
   "segmentCount": 1,
   "elementCount": 107,
   "unitCount": 4,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ffd/2025": 14,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/ffd/role/document/submissionTable",
     "longName": "995210 - Document - Submission",
     "shortName": "Submission",
     "isDefault": "true",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2025-06-20",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ss4963221_ex107.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-06-20",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ss4963221_ex107.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
     "longName": "995211 - Document - Offerings",
     "shortName": "Offerings",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "From2025-06-202025-06-20_1",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ss4963221_ex107.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-06-202025-06-20_1",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ss4963221_ex107.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable",
     "longName": "995215 - Document - Fees Summary",
     "shortName": "Fees Summary",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "3",
     "firstAnchor": {
      "contextRef": "AsOf2025-06-20",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ss4963221_ex107.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-06-20",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ss4963221_ex107.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ffd_AggtRedRpPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtRedRpPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtRedRpPricPrrFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtRedRpPricPrrFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Prior Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, Prior FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtSalesPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtSalesPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Sales Price, Fiscal Year",
        "terseLabel": "Aggregate Sales Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtRedCdts": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtRedCdts",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Redemption Credits",
        "terseLabel": "Redemption Credits"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtSctiesRcvd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Received",
        "terseLabel": "Amount of Securities Received",
        "documentation": "Amount of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_AmtSctiesRegd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtSctiesRegd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Registered",
        "terseLabel": "Amount Registered",
        "documentation": "The amount of securities being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CeasedOprsDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CeasedOprsDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ceased Operations Date",
        "terseLabel": "Ceased Operations Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CfwdFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Form Type",
        "terseLabel": "Carry Forward Form Type",
        "documentation": "The Form Type of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrevslyPdFee": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrevslyPdFee",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Previously Paid Fee",
        "terseLabel": "Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward",
        "documentation": "The fee previously paid in connection with the securities being brought forward from the prior shelf registration statement on which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrrFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Prior Effective Date",
        "terseLabel": "Carry Forward Initial Effective Date",
        "documentation": "The initial effective date of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward File Number",
        "terseLabel": "Carry Forward File Number",
        "documentation": "The EDGAR File Number of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). If the prior registration statement has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CmbndPrspctsItemAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsItemAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Item [Axis]",
        "terseLabel": "Combined Prospectus",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different references to earlier prospectuses on a single fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Line Items]",
        "terseLabel": "Combined Prospectus:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Table]",
        "terseLabel": "Combined Prospectus Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CombinedProspectusTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CombinedProspectusTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Table [N/A]",
        "terseLabel": "Combined Prospectus Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CshPdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CshPdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Paid by Registrant in Transaction",
        "terseLabel": "Cash Consideration Paid",
        "documentation": "Amount of cash consideration paid by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "ffd_CshRcvdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CshRcvdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Received by Registrant in Transaction",
        "terseLabel": "Cash Consideration Received",
        "documentation": "Amount of cash consideration received by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "ffd_FeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Amount",
        "terseLabel": "Amount of Registration Fee",
        "documentation": "Total amount of registration fee (amount due after offsets)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeExhibitTp": {
     "xbrltype": "feeExhibitTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeExhibitTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Exhibit Type",
        "terseLabel": "Fee Exhibit Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_FeeIntrstAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Interest Amount",
        "terseLabel": "Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note",
        "terseLabel": "Fee Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNoteMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeNoteMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note Maximum Aggregate Offering Price",
        "terseLabel": "Fee Note MAOP"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeRate",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Rate",
        "terseLabel": "Fee Rate",
        "documentation": "The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesOthrRuleFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeesOthrRuleFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees, Other Rule [Flag]",
        "terseLabel": "Other Rule",
        "documentation": "Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesSummaryLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeesSummaryLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees Summary [Line Items]",
        "terseLabel": "Fees Summary:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FnlPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FnlPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Final Prospectus [Flag]",
        "terseLabel": "Final Prospectus"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FormTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Form Type",
        "terseLabel": "Form Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_GnlInstrIIhiFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "GnlInstrIIhiFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Instruction II.H,I [Flag]",
        "terseLabel": "General Instruction II.H,I"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrCity": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrCity",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, City",
        "terseLabel": "City"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStatOrCtryCd": {
     "xbrltype": "stateOrCountryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStatOrCtryCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, State or Country Code",
        "terseLabel": "State or Country Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt1": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStrt1",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 1",
        "terseLabel": "Street 1"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt2": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStrt2",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 2",
        "terseLabel": "Street 2"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrZipCd": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrZipCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Zip Code",
        "terseLabel": "Zip Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrNm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Name",
        "terseLabel": "Issuer Name"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_MaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "MaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Aggregate Offering Price",
        "terseLabel": "Maximum Aggregate Offering Price",
        "documentation": "The maximum aggregate offering price for the offering that is being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_MaxOfferingPricPerScty": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "MaxOfferingPricPerScty",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Offering Price per Security",
        "terseLabel": "Proposed Maximum Offering Price per Unit",
        "documentation": "The maximum offering price per share/unit being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetFeeAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NetFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Fee Amount",
        "terseLabel": "Net Fee"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetSalesAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NetSalesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Sales Amount",
        "terseLabel": "Net Sales"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvDsclsr": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvDsclsr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure",
        "terseLabel": "Narrative Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvMaxAggtAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Amount",
        "terseLabel": "Narrative - Max Aggregate Offering Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Price",
        "terseLabel": "Narrative - Max Aggregate Offering Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Axis]",
        "terseLabel": "Offering",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different security offerings on a single fee bearing submission."
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Line Items]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Note",
        "terseLabel": "Offering Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Title",
        "terseLabel": "Security Class Title",
        "documentation": "The title of the class of securities being registered (for each class being registered)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Type",
        "terseLabel": "Security Type",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Table]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Table [N/A]",
        "terseLabel": "Offering Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset [Axis]",
        "terseLabel": "Offset",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different offsets as applied to a fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetClmInitlFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmInitlFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claim Initial Filing Date",
        "terseLabel": "Initial Filing Date",
        "documentation": "The initial filing date of the earlier registration statement with which the earlier (offsetting) fee was paid for a claimed offset. If the offset fee was paid with an amendment, do not provide the amendment date under this element; instead, provide the date of the initial filing (i.e. the \"parent\" filing) ."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Amount",
        "terseLabel": "Fee Offset Claimed",
        "documentation": "The amount of offsetting fees being claimed."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdInd": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmdInd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Indicator",
        "terseLabel": "Offset Claimed"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetExpltnForClmdAmt": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetExpltnForClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Explanation for Claimed Amount",
        "terseLabel": "Explanation for Claimed Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetLineItems",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset:",
        "label": "Offset [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Note",
        "terseLabel": "Offset Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetPrrFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Fee Amount",
        "terseLabel": "Fee Paid with Fee Offset Source",
        "documentation": "The fee previously paid from which an offset is being derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior File Number",
        "terseLabel": "File Number",
        "documentation": "The EDGAR File Number of the earlier registration statement with which the earlier (offsetting) fee was paid. If the offset filing for the offset has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFilerNm": {
     "xbrltype": "filerNameItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFilerNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Filer Name",
        "terseLabel": "Registrant or Filer Name",
        "documentation": "The name of the registrant that filed the earlier registration statement with which the earlier (offsetting) fee was paid."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Form Type",
        "terseLabel": "Form or Filing Type",
        "documentation": "The Form Type of the offset filing."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrNbOfUnsoldScties": {
     "xbrltype": "nonNegativeIntegerItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrNbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Number of Securities",
        "terseLabel": "Unsold Securities Associated with Fee Offset Claimed",
        "documentation": "The number of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Title",
        "terseLabel": "Security Title Associated with Fee Offset Claimed",
        "documentation": "The title of the class of securities from which offset fees were derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Type",
        "terseLabel": "Security Type Associated with Fee Offset Claimed",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrUnsoldOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrUnsoldOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Offering Amount",
        "terseLabel": "Unsold Aggregate Offering Amount Associated with Fee Offset Claimed",
        "documentation": "The aggregate offering amount of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetSrcFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetSrcFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Source Filing Date",
        "terseLabel": "Filing Date",
        "documentation": "The filing date of the earlier registration statement with which the earlier (offsetting) fee was paid in an offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset Payment:",
        "label": "Offset [Table]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Table [N/A]",
        "terseLabel": "Offset Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_PrevslyPdFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "PrevslyPdFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Previously Paid [Flag]",
        "terseLabel": "Fee Previously Paid"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RegnFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "RegnFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration File Number",
        "terseLabel": "Registration File Number"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RptgFsclYrEndDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "RptgFsclYrEndDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reporting Fiscal Year End Date",
        "terseLabel": "Reporting FY End Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule011Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 0-11 [Flag]",
        "terseLabel": "Rule 0-11"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011a2OffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule011a2OffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 0-11(a)(2) Offset",
        "label": "Rule 0-11(a)(2) Offset [Flag]"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule415a6Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule415a6Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 415(a)(6) [Flag]",
        "terseLabel": "Rule 415(a)(6)",
        "documentation": "Checkbox indicating whether filer is claiming a 415(a)(6) carryforward."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_Rule429AggtOfferingAmt": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429AggtOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Aggregate Offering Amount",
        "terseLabel": "Maximum Aggregate Offering Price of Securities Previously Registered",
        "documentation": "The maximum aggregate offering amount of unsold securities registered on the prior registration statement that are carried forward under Rule 429. Only applicable if 457(o) was used in the fee calculation for the prior registration statement."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429CmbndPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429CmbndPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Combined Prospectus [Flag]",
        "terseLabel": "Rule 429",
        "documentation": "Checkbox indicating whether filer is using a combined prospectus under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429EarlierFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier File Number",
        "terseLabel": "File Number",
        "documentation": "The Securities Act File Number of the earlier effective registration statement(s) from which securities may be offered and sold using the combined prospectus pursuant to Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429EarlierFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier Form Type",
        "terseLabel": "Form Type",
        "documentation": "The Form Type of the earlier registration statement from which unsold securities are carried forward under Rule 429. This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429InitlFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429InitlFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Initial Effective Date",
        "terseLabel": "Initial Effective Date",
        "documentation": "The filing date of the earlier registration statement from which unsold securities are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429NbOfUnsoldScties": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429NbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Number Of Unsold Securities",
        "terseLabel": "Amount of Securities Previously Registered",
        "documentation": "The number of securities registered on the prior registration statement that are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429PrspctsNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429PrspctsNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Prospectus Note",
        "terseLabel": "Combined Prospectus Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429SctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Title",
        "terseLabel": "Security Class Title"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429SctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Type",
        "terseLabel": "Security Type"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule457aFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457aFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(a) [Flag]",
        "terseLabel": "Rule 457(a)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(a) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ffd_Rule457bOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457bOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(b) Offset [Flag]",
        "terseLabel": "Rule 457(b) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(b) or 0-11(a)(2)."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ffd_Rule457fFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457fFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(f) [Flag]",
        "terseLabel": "Rule 457(f)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_Rule457oFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457oFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(o) [Flag]",
        "terseLabel": "Rule 457(o)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(o) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "ffd_Rule457pOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457pOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(p) Offset [Flag]",
        "terseLabel": "Rule 457(p) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(p)."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "ffd_Rule457rFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457rFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(r) [Flag]",
        "terseLabel": "Rule 457(r)"
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "ffd_Rule457sFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457sFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(s) Flag",
        "terseLabel": "Rule 457(s)"
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "ffd_Rule457uFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457uFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(u) [Flag]",
        "terseLabel": "Rule 457(u)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(u) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "ffd_Scties424iAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Axis]",
        "terseLabel": "Securities, 424I"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Line Items]",
        "terseLabel": "Securities, 424I:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Table]",
        "terseLabel": "Securities, 424I Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Securities424iTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Securities424iNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities 424I [N/A]",
        "terseLabel": "Securities 424I N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "SubmissionLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission [Line Items]",
        "terseLabel": "Items"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissnTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "SubmissnTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission Type",
        "terseLabel": "Submission Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TermntnCmpltnWdrwl": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TermntnCmpltnWdrwl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination / Completion / Withdrawal Statement",
        "terseLabel": "Termination / Withdrawal Statement"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TtlFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee Amount",
        "terseLabel": "Total Fee Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlFeeAndIntrstAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlFeeAndIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee and Interest Amount",
        "terseLabel": "Total Fee and Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offering Amount",
        "terseLabel": "Total Offering"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOffsetAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlOffsetAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offset Amount",
        "terseLabel": "Total Offset Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlPrevslyPdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlPrevslyPdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Previously Paid Amount",
        "terseLabel": "Previously Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlTxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlTxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Transaction Valuation",
        "terseLabel": "Total Transaction Valuation"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction Valuation",
        "terseLabel": "Transaction Valuation"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_ValSctiesRcvd": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "ValSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received",
        "terseLabel": "Value of Securities Received",
        "documentation": "Value of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_ValSctiesRcvdPerShr": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "ValSctiesRcvdPerShr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received, Per Share",
        "terseLabel": "Value of Securities Received, Per Share",
        "documentation": "Value per share of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form). This is included in the explanation of 457(f) fee calculation."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "415",
   "Subsection": "a"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "429"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "f"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "o"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "p"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "r"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "s"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "u"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Subsection": "f",
   "Section": "457"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>19
<FILENAME>0000947871-25-000621-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000947871-25-000621-xbrl.zip
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M<P>=N_).#SH/'GS^Y#V#_$ATAW<,4D%^N+M;]/ "B1[.']EKOWRX7<J)W13
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-  $ 00   ,8-      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>ss4963221_ex107_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:ffd="http://xbrl.sec.gov/ffd/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef
      xlink:href="https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd"
      xlink:type="simple"/>
    <context id="AsOf2025-06-20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <startDate>2025-06-20</startDate>
            <endDate>2025-06-20</endDate>
        </period>
    </context>
    <context id="From2025-06-202025-06-20_1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>1</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-06-20</startDate>
            <endDate>2025-06-20</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Ratio">
        <measure>pure</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="AsOf2025-06-20" id="Fact000003">0001022079</dei:EntityCentralIndexKey>
    <ffd:SubmissnTp contextRef="AsOf2025-06-20" id="Fact000009">S-3ASR</ffd:SubmissnTp>
    <ffd:FeeExhibitTp contextRef="AsOf2025-06-20" id="Fact000010">EX-FILING FEES</ffd:FeeExhibitTp>
    <ffd:FormTp contextRef="AsOf2025-06-20" id="Fact000011">S-3</ffd:FormTp>
    <dei:EntityRegistrantName contextRef="AsOf2025-06-20" id="Fact000012">Quest Diagnostics Incorporated</dei:EntityRegistrantName>
    <ffd:PrevslyPdFlg contextRef="From2025-06-202025-06-20_1" id="Fact000013">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="From2025-06-202025-06-20_1" id="Fact000014">Debt</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="From2025-06-202025-06-20_1" id="Fact000015">Debt Securities</ffd:OfferingSctyTitl>
    <ffd:Rule457rFlg contextRef="From2025-06-202025-06-20_1" id="Fact000016">true</ffd:Rule457rFlg>
    <ffd:FeeRate
      contextRef="From2025-06-202025-06-20_1"
      decimals="INF"
      id="Fact000017"
      unitRef="Ratio">0.000001531</ffd:FeeRate>
    <ffd:TtlOfferingAmt
      contextRef="AsOf2025-06-20"
      decimals="0"
      id="Fact000018"
      unitRef="USD">0.00</ffd:TtlOfferingAmt>
    <ffd:TtlFeeAmt
      contextRef="AsOf2025-06-20"
      decimals="0"
      id="Fact000019"
      unitRef="USD">0.00</ffd:TtlFeeAmt>
    <ffd:TtlPrevslyPdAmt
      contextRef="AsOf2025-06-20"
      decimals="0"
      id="Fact000020"
      unitRef="USD">0.00</ffd:TtlPrevslyPdAmt>
    <ffd:TtlOffsetAmt
      contextRef="AsOf2025-06-20"
      decimals="0"
      id="Fact000021"
      unitRef="USD">0.00</ffd:TtlOffsetAmt>
    <ffd:NetFeeAmt
      contextRef="AsOf2025-06-20"
      decimals="0"
      id="Fact000022"
      unitRef="USD">0.00</ffd:NetFeeAmt>
    <ffd:OfferingNote contextRef="From2025-06-202025-06-20_1" id="Fact000023">The registrant is relying on Rule 456(b) and Rule 457(r) under the Securities Act of 1933, as amended, to defer payment of all of
the registration fee. In connection with the securities offered hereby, the registrant will pay &#x201c;pay-as-you-go registration fees&#x201d;
in accordance with Rule 456(b). The registrant will calculate the registration fee applicable to an offer of securities pursuant to this
registration statement based on the fee payment rate in effect on the date of such fee payment. An unspecified aggregate initial offering
price and number of securities of the identified class is being registered and may from time to time be offered at unspecified prices.</ffd:OfferingNote>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
